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CHAPTER ONE 
Attention-deficit Hyperactive Disorder (ADHD) is the most 
common childhood psychiatric disorder and accounts for at least half of all 
referrals to child guidance centers in the United States (Taylor, 1990). 
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Research indicates that among the general population between 2% and 10% of 
the children suffer from ADHD. Clinical experience supports a much higher 
incidence in the population, closer to 20% {Taylor, 1990). Several studies found 
that approximately 3% of the children in the United States are medicated for 
ADHD (Taylor, 1990; Bosco & Robin, 1980; Sandoval, Lambert & Sassone,1980). 
Safer and Krager (1988) conducted nine surveys and found a number of 
interesting facts: (a) Every. four to seven years the rate of medication for 
elementary age children is doubling; in 1987, it reached nearly 6%; (b) the 
diagnosis of ADHD is 6 to 8 times more common among males than females 
(Dulcan 1986); (c) ADHD is estimated to occur in 6% of the US. Population: 10% 
of the males and 2% of the females; ( d) children with ADHD constitute 30 to 50% 
of the child psychiatric outpatients and 40 to 70% of the inpatients; ( e) other 
disorders frequently coexist with ADHD, particularly conduct disorders (up to 
70%) and developmental learning disorders (20-70%), and (f) children with 
autism, Tourette's syndrome and mental retardation will also have serious 
ADHD symptoms more than 25% of the time. 
The treatment of ADHD children is extremely controversial and many 
times the treatment is not based upon empirical or theoretical principles. The 
treatments that are most frequently used include medication, parent training, 
social skills training for the children, counseling for the children or families, 
educational interventions, behavior management and finally combinations of 
these treatments. The use of medication is particularly controversial and has 
come under attack from zealous groups that purport to represent the 
children's rights. The use of psychopharmacological treatments for children 
is still so new that there is a noticeable absence of long-term studies (Barkley, 
1991 b). Psychopharmacological treatment is by far the most widely 
researched type of treatment for ADHD, with over .900 studies since 1983 
(Wilens & Biederman, 1992). 
A meta-analytical review of the treatments for ADHD has not been 
performed to date. Moreover, there are only a few reviews of treatment for 
ADHD but they take a very general approach and are descriptive in nature. 
None of the reviews investigate the multiple types of dependent variables in 
order to measure which areas of the child's life show improvement after 
treatment. Educational research has a particular problem in producing so 
many conflicting results that it is difficult if not impossible to determine 
trends and draw conclusions (Bangert-Drowns, 1991). Meta-analysis is 
especially helpful in placing results from many studies into a common metric 
and then exploring the relationships between the various studies and their 
findings. More specifically, a meta-analytic review of pychopharmacological 
treatment of ADHD is needed. 
There are three classes of medication for the treatment of ADHD; within 
two of the classes, there are many specific medications that are used. The 
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three general classes of medication include stimulants, antidepressants and 
antihypertensives. Within the stimulant class, pemoline (Cylert), 
methylphenidate (MPH; Ritalin) and d-amphetamine (Dexedrine) are three 
that are commonly used. Within the antidepressants, the most commonly used 
are imipramine (Tofranil), desipramine (Norpramine) and fluoxetine (Prozac). 
The only medication that has been used with any regularity in the 
antihypertensive class is clonidine (Catapres) and even though it has been 
used for many years for controlling high blood pressure, it has only recently 
been used in the treatment of ADHD children. 
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As previously stated, the use of medication for treating ADHD children is 
the most widely researched type of treatment, with more than 900 published 
articles since 1983 (Wilens & Biederman, 1992). Wilens and Biederman (1992) 
reviewed more than 230 articles that evaluated the efficacy of stimulant 
medication and concluded for children of all ages, stimulants were effective in 
65-75% of the children, while other scientists have found the success rate at 
75% when based upon teacher's ratings (Greenhill, 1992; Fornes_s, Swanson, 
Cantwell, Youpa & Hanna, 1992). 
The previous research investigating the efficacy of medication in 
treating ADHD children has not compared the various classes of medication in 
order to determine which is most effective. Comparing the different types of 
medication to each other is important, especially in order to separate what part 
of the child's life is most improved by the different types of medications and 
with which type of child. 
The study of treatment effectiveness for ADHD children is confused by 
the multiple dependent measures that are commonly used to assess treatment 
effectiveness. To a large extent, effectiveness is determined by the way one 
chooses to measure it. Some of the general categories that are frequently used 
to measure effectiveness include parent behavior ratings, teacher behavior 
ratings, miscellaneous behavior ratings, academic achievement, standardized 
assessments, direct observation, measurement of social interactions, self-
esteem and self-ratings. Within each of these categories there are multiple 
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more specific measures to assess treatment effectiveness. The way the 
dependent measures are set up makes a meaningful statement about the nature 
of the body of research that has been performed in this field. Virtually all of 
the measures are short-term in nature and do not measure long-term outcome, 
as well as fail to consider developmental factors that have consistently been 
shown to have significant impact on all aspects of a child's life. 
It is important when using meta-analytic procedures to also take into 
account both subject characteristics and study characteristics. Both factors 
can potentially influence the outcome of each study. Study variables that will 
be considered in this project include the rigor of criteria used to defme the 
treatment subjects, the number of weeks exposed to treatment, and sample size 
of the treatment group. The subject variables that will be considered include 
age of the subjects and IQ of the subjects which received treatment. 
Purpose of Study 
The purpose of this study is to determine the effectiveness of using 
medication for the treatment of children and adolescents who have ADHD. 
Meta-analysis will be used on selected published .studies to determine which 
medication is most effective and at what dosage rate Additionally, this study 
should determine which dependent measures are most improved by which 
medication and at what dose. By separating and measuring some of the 
extraneous variables within the studies, It is hoped that some of the confusion 
that surrounds the treatment with medication of ADHD will be clarified. 
Research Questions 
Given the aforementioned purpose, the following research questions 
are addressed and when applicable, null hypotheses are listed. 
s 
1. Does the use of medication significantly improve the overall 
performance as measured by the average of all measures of ADHD 
children and adolescents when compared to the placebo treatment? 
2. Does the use of medication significantly improve parent behavior 
ratings of the ADHD children when compared to the placebo treatment? 
3. Does the use of medication significantly improve teacher behavior 
ratings of the ADHD children when compared to the placebo treatment? 
4. Does the use of medication significantly improve the academic 
achievement of ADHD children when compared to the placebo 
treatment? 
S. Does the use of medication significantly improve performance of the 
ADHD children on standardized assessments when compared to the 
placebo treatment? 
6. Does the use of medication significantly improve the behavior of ADHD 
children when compared to the placebo treatment as measured by direct 
observation of their behavior? 
7. Does the use of medication significantly improve the social interactions 
of the ADHD children when compared to the placebo treatment? 
8. Does the use of medication significantly improve the self-esteem ratings 
of ADHD children when compared to the placebo treatment? 
9. Does the use of medication significantly improve the self-ratings of 
ADHD children in various areas when compared to the placebo 
treatment? 
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10. Does the use of medication improve the behavior ratings of people other 
than teachers and parents as compared to the placebo treatment? 
11. Will there be differences in the overall effectiveness between 
stimulants and antidepressants? 
12. Will there be differences between the low, medium, and high dosage 
levels for methylphenidate MPH as measured by the ten outcome 
categories? 
13. What is the relationship between the IQ of the subjects and their 
response to medication as measured by the ten outcome categories? 
14. What is the relationship between the age of the subjects and their 
response to medication as measured by the ten outcome categories? 
15. What is the relationship between the level of rigor which the studies 
used to select subjects and the ten outcome categories? 
16. What is the relationship between the number of subjects in the studies 
and the ten outcome categories for all medications? 
17. What is the relationship between the number of weeks exposed to 
treatment and the global improvements? 
18. Are there any differences between the different types of stimulant 
medication as measured by the average of the nine outcome categories? 
Assumptions 
It is assumed that ADHD constitutes a unidimensional disorder, which 
includes inattention, impulsivity and hyperactivity, and that it is distinct from 
any other disorder listed in the DSM 111-R (American Psychological 
Association, 1987; APA). It is further assumed that proper diligence and care 
were taken to collect the data in the studies that are included for analysis in 
this study. Furthermore, it is assumed that prudent design principles guided 
the procedures in the studies including sample selection, statistical analysis, 
and reporting of the results. 
I.imitations 
A major limitation of this study is the generalizability to all 
experimental treatments that have been performed but not published and 
those which do not appear on the £8..Y-chscan and Medline computer search 
data bases. Dissertations and theses were excluded because of the 
inconsistency in the rigor of design and statistical analysis. There is a 
publication bias (Hedges, 1987) which occurs when only published studies are 
selected, and Hedges explains that, "There is considerable empirical evidence 
that the published literature coritains fewer statistically insignificant results 
than would be expected from the complete collection of all studies actually 
conducted" (p. 365). There is a rigorous selection procedure that takes place 
before a study is published, which could cause a systematic bias. There is an 
alternative argument that posits that this selection procedure improves the 
rigor and excludes poorly designed studies that could cause less accurate 
results and greater experimental error. 
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Another limitation which all meta-analyses have is dependence on the 
dependent measures which the studies utilized. Rather than selecting 
dependent variables which would be most appropriate, this study was confined 
to using only the measures which were available within the body of literature 
that met the inclusion criterion. 
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A final limitation of this study which is critically important is that this 
study only looked at the positive benefits of medication. There is a brief 
description of the potential side effects of medication in this study but this 
study does not propose to provide equal information on the negative side of the 
argument. For more detailed information regarding the negative aspects of 
giving medication to ADHD children, other sources will need to be researched. 
All factors need to be considered, both negative and positive, before a decision 
to place a child on medicine is made. Additionally, there are many other forms 
of treatment for ADHD children which do not use medication and this study did 
address each of those adequately but in no way does this imply that other 
treatments should not be pursued. It is hoped that future research will look at 
other types of treatment or combinations of treatment with ADHD children. 
Definition of Terms 
Relevant terms used in classifying the dependent variables from the studies 
that are included for analysis in this study are defined in the following way: 
Parent behavior ratings.: There are many different forms of behavior 
ratings that are completed by parents for the child's behavior. The behavior 
rating form includes questions about the frequency of certain problem 
behaviors and typically the various questions are combined to form factor 
scores, which have been standardized and normed. The behavior ratings do 
not include direct observation of behavior or counting the number of times a 
behavior occurs within a specified time period. 
Teacher behavior ratings: These are similar to the parent ratings but 
are completed by teachers or counselors that observe the child in a school 
setting. Some of the teacher behavior rating forms have the same questions as 
the parent forms and some of them have questions that are specific to the 
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school setting. These behavior ratings do not include direct observation of the 
child's behavior or counting the number of times a specific behavior occurs 
within a specified time period. 
Misce11aneous behavior ratings: This includes any type of behavior 
rating of the child by someone other than a parent or teacher. Examples could 
include hospital workers, clinicians or camp counselors. 
Academic achievement: This includes all types of academic 
achievements such as math, reading or listening comprehension and could 
include such items as number of items answered correctly, the number of 
items completed, or the time to complete the test. It may include standardized 
school achievement tests or any type of specialized school related assessment. 
Standardized assessments: This includes such tasks as continuous 
performance tests (CPT), matching figures among many similar items, and 
matching colored items with different shapes and sizes. All of the assessment 
tools are used to measure an aspect of sustained attention, vigilance, 
distractibility or impulse control. 
Direct observation: This involves counting or coding behavior while it 
is occurring and could include such items as percentage of on task behavior, 
percentage of time the child is in his/her seat during the performance of a 
task, the number of times the child wiggles or fidgets or the number of times 
the child talks. The direct observations include all settings such as home, 
school, summer camp, hospitals or clinics. 
Social interactions: This includes coding the behavior of the ADHD child 
while he/she interacts with other children and usually includes measuring 
the amount prosocial or antisocial behavior. It also includes behavior such as 
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compliance with rules, amount of arguing with peers and ratings by peers or 
mental health experts. If the ratings include direct observation of the ADHD 
child interacting with peers, it will be included in this category rather than 
the direct observation category. Furthermore, if the dependent measure 
includes a behavior rating but is based upon peer interaction, it will be 
included in this category rather than behavior ratings. 
Self rating: This includes all measures completed by the child on 
himself. It measures how he/she is perceived to be doing in some area such as 
behavior compliance or efficacy on a task. 
Self-Esteem: This category is used for all types of self-esteem 
assessments. It may include standardized ratings completed by others or by 
the child. If the assessment instrument is for self- esteem, it will be placed in 
this category rather than the self-rating category. 
Effect Size: It is a metric-free index that measures the effectiveness of 
treatment and can be conceptualized as the difference between population 
means (;\). If the treatment and placebo means are equal, then the effect size 
is zero. There are many ways to compute the effect size but this study used the 
method developed by Glass (1981) which subtracts the difference in the means 
for the placebo and treatment groups and divides the result by the standard 
deviation of the placebo group. Because there is typically greater variability 
in the placebo treatment, this method of computing effect sizes usually results 
in a conservative estimate ( Cooper & Hedges, 1994). 
Attention-deficit HyperactivitY- Disorder: is a disorder of behavior that 
has as its primary components impulsivity, inattentiveness and hyperactivity. 
lmpulsivity involves acting upon impulse rather than thought. Inattention 
involves the concentration of mental powers upon an object (Morris, 1969). 
Hyperactivity involves an excessive or abnormal level of activity. 
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Meta-Analysis: is "any literature review that makes explicit use of 
quantitative methods to express the results of studies or to combine those 
results across studies" (Hedges, 1987; p. 353). Meta~analysis involves the 
analytical review of multiple studies using different dependent variables and 
different scales, and statistically measuring trends of effectiveness and the 
strength of those trends. 
Historical View 
CHAPTER 1WO 
Review of Literature 
Nature and Diagnosis of ADHD 
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The core symptoms that have defined attention problems and excessive 
motor activity have changed as frequently as the names for the disorder have 
changed. The way we define disorders is more than an academic exercise 
because the way children's problems are categorized, influences to a large 
extent, the way they are treated by practitioners and caretakers and 
determines their eligibility for services. The way a disorder is categorized has 
everything to do with the way its causes, correlates, developmental courses 
and consequences are formulated (Renker & Whalen, 199 la). The earliest 
emphasis by Still in 1902 placed the key features on the moral character of the 
children and to some extent he emphasized behavioral disinhibition (Barkley, 
1991a). For the next several decades, there was little interest in research and 
the research that was conducted placed the emphasis upon hyperactivity and 
conduct disturbance. 
In the middle part of the nineteenth century, there was an increased 
interest in ADHD research· by Strauss and Lehtinen ( 194 7) who wrote an article 
that created enthusiasm among many scientists. They placed an emphasis on 
inattention and restlessness and hypothesized that it was due to brain damage 
since previous findings indicated that people that had suffered brain trauma 
exhibited the same symptoms. Consequently, even though there was no 
history of brain injury, i:t was surmised there must be minimal brain damage. 
This began the concept of "minimal brain damage" shortened to MBD. The 
emphasis upon distractibility had educational implications that usually called 
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for removing all potential distracting stimuli from the classroom and making 
the environment as bland and sterile as possible. Eventually when no brain 
damage could be located, the label was changed to "minimal brain dysfunction" 
and researchers tried to find psychometric evidence that the brain was not 
functioning properly. ContiJiued research did not provide any solid support 
for neurological damage and a new diagnostic term became popular. The 
disorder became known as "Hyperkinetic Reaction in Childhood" (DSM III, 
APA, 1968) and placed the greatest emphasis upon the excessive motor activity. 
In the middle part of the 1970s, research provided support for acute and 
chronic problems with inattention and impulsivity, as well as the problems 
With hyperactivity (Douglass, 1972). Douglass (cited in Mash & Barkley, 1989, p. 
40) conducted research that argued that children that were called hyperactive, 
actually had deficits in four primary areas: " ( a) investment, organization and 
maintenance of attention, (b) the inhibition of impulsive responding, (c) the 
modulation of arousal levels to meet situational demands; and (d) a strong 
tendency to seek immediate reinforcement." This definition relegated 
hyperactivity to an equal status with inattention and impulsivity. Douglass 
provided enough persuasive evidence for a syndromal approach that the DSM 
III (APA, 1983) formed two distinct categories called Attention-deficit Disorder 
with Hyperactivity (ADD-H) and Attention-deficit Disorder without 
Hyperactivity (ADD). Both category names removed the emphasis from 
hyperactivity and upon the problems with attention. 
The scientific community in Britain placed their emphasis on symptoms 
of conduct disturbance and in fact doesn't recognize the diagnosis of attention 
deficit to be distinct from conduct disorders. Current research using factor 
analysis has dearly yielded distinct but overlapping factors of 
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defiant/aggressive behavior and hyperactivity (Barkley, 1989). Additionally, 
research has shown hyperactive children to differ from conduct disordered 
children because they exhibit more developmental clelays in language and 
motor skills, pervasiveness of overactivity across settings, and difficulties. in 
sustained attention to boring, repetitive tasks (Milich, Loney, & Landau, 1982; 
Werry, Reeves, & Elkind, 1987). 
Associated Features of ADHD 
Research has consistently supported a multitude of symptoms beyond 
the core symptoms, previously discussed. Many scientists believe that the 
associated or secondary deficits pose more lasting and pervasive problems for 
the ADHD child than the primary symptoms (Mash & Barkley, 1989). A partial 
list of the secondary symptoms that is supported by research includes 
impairment in the following areas: cognition and memory, academic and 
learning disabilities, speech and language development, sensory and motor 
delays, minor physical anomalies, sleep patterns, emotional disorders, conduct 
and behavioral disturbance, social relationship problems and parent-child 
conillcts. There is a far greater volume of research done with ADHD males 
than ADHD females. Frequently, clinical lore reports that ADHD males exhibit 
more behavior problems, academic problems and in general, exhibit more of 
the core symptoms of ADHD than do females. Breen (1989) compared ADHD 
males and females on a large number of problem areas and he found that ADHD 
boys and girls did not differ from each other on any of the performance or 
behavior rating scales but both differed from normal subjects significantly. 
This study indicates that gender does not play a significant role in 
determining the degree of problems or the need for intervention that an ADHD 
child will need. 
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Intel1igence, Cognition and Memory 
There is much controversy over whether ADHD children actually have 
lower IQs or whether their inattention, impulsivity and hyperactivity hamper 
their performance on an IQ test. Several studies have indicated that ADHD 
children score an average of 7 to 15 points lower on standardized intelligence 
tests than non-ADHD children (Fischer, Barkley, Edelbrock & Smallish, 1991; 
Tarver-Behring, Barkley & Karlsson, 1985; Barkley, 1990); however, other 
studies have not found any significant difference in the Full Scale IQ on the 
Wechsler but have found various subtests to accurately differentiate ADHD 
children from normals (Phelps, Rosso & Falasco, 1985; Sutter, Bishop & Battin, 
1987; Grant, Ilai, Nussbaum & Bigler, 1990; Carlson, Lahey, & Neeper, 1986~ Lufi, 
Cohen & Parish-Plass, 1990). Another potential explanation for poor 
performance by ADHD children on intelligence tests is due to their poor 
academic performance, which precipitates low expectancy and low effort 
during the IQ test. 
The term pervasive ADHD is used in the literature to indicate when a 
child exhibits ADHD symptoms in all settings such as school and home, whereas 
situational ADHD is when a child exhibits symptoms in only one setting. 
Boudreault, Thivierge, Cote., Boutin, Yves and Bergeron (1988) compared 
pervasive ADHD, situational ADHD and normal children on several key 
cognitive variables and found that pervasive ADHD children were 
significantly lower than normal children on verbal IQ, non-verbal IQ, global 
IQ, and the distractibility factor. The situational ADHD children were 
significantly lower than the normals on verbal IQ and global IQ only. The only 
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measure in which the two ADHD groups differed was on verbal IQ, with the 
pervasive ADHD group scoring about 8 points lower than the situational group. 
ADHD children have not only experienced difficulty intellectually but 
consistently have trouble with problem-solving strategies and organization 
skills (Hamlett, Pellegrini & Conner, 1987; Tant & Douglass, 1982). They also 
seem to apply fewer strategies in solving memory tasks (Voelker, Carter, 
Sprague, Gdowski & Lachar, 1989). The problems they experience don't seem to 
be the result of skill deficits in organizing or the knowledge of how to 
organize, but rather they don't utilize or put into action what they know 
(Barkley, 1990). Barkley (1990, p. 78-79) summarized the results from several 
studies involving the ways ADHD children solve problems and process 
information. He concluded the following: (a) ADHD children have difficulty 
communicating their problem solving strategy to others, (b) ADHD children 
have greater difficulty with "rule-governed behavior including problem-
solving or self-generating rules that get in the way of tasks that require rule 
discovery and communication of those rules to others," (c) ADHD children 
have "significant deficits in executive processes such as strategies or 
mechanisms used by individuals to orchestrate or organize and monitor their 
own thoughts." 
Neurocognitive impairment is thought to be caused by maturational 
delays in the brain (Rourke, 1982). Some of the most common areas of 
impairment that typically constitute neurocognitive impairment includes: 
language, visual-perceptual functioning, motor coordination, and problem 
solving skills (Szatmari, Offord, Siegel, Finlayson & Tuff, 1989). ADHD children 
reportedly suffer from a much higher incidence of neurocognitive 
impairments than normal children or even children with other psychiatric 
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disorders (Szatmari et al., 1989). Szatmari et al. took a sample of clinic referred 
children and gave them multiple test instruments that measure 
neurocognitive impairment. They wanted to compare the results of the testing 
with the diagnosis that the children were given to see if particular disorders 
would be associated with certain impairment. They were able to place all of 
the children into either an ADHD-conduct disordered group or anxiety-
affective disordered group. A discriminant function was conducted and they 
found three tests that accurately separated the two groups 79% of the time 
(93% of the ADHD-conduct group and 41% of those with anxiety-affective 
disorder). The three tests that discriminated the ADHD-conduct group from the 
anxiety-affective group included the perceptual organization and verbal 
comprehension on the Wechsler (WISC-R), and the Pegs test that measures 
vigilance or attention. The ADHD-conduct group performed lower on all three 
measures. 
Academic and Learning Disabilities 
One of the primary areas of difficulties that the ADHD children suffer is 
with academic achievement and performance. Almost all ADHD children who 
are referred to clinics are performing poorly in school and typically 
underachieve (math, spelling & reading) relative to their known cognitive 
abilities based on intelligence tests (Barkley, 1991; 1992b; Barkley, 
Anastopoulos, Guevremont & Fletcher, 1991; Barkley, Guevremont & Fletcher, 
1991). Up to 25% of the ADHD children have specific learning disabilities and 
ADHD children score between 7 and 15 standardized points lower than their 
peers on national academic achievement tests. Up to 40% of the ADHD children 
will be placed in some type of special education program for behavior or 
academic problems. Between 20 and 35% will be retained in at least one grade 
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before reaching high school (Barkley, 1992b). The most common areas of 
disability are math, spelling and reading (especially in comprehension). 
ADHD children are about twice as likely to have expressive language problems 
compared to normal children (Barkley, 1992). Monoz-Millan and Casteel (1989) 
found that hyperactive adolescents are, on the average, two grades behind 
their peers in academic performance. They hypothesize that it is due both to 
poor learning strategies and poor learning behavior in the classroom. 
There are a number of methods used to determine whether a child 
qualifies for LD services. Barkley (1990) found that 26% of the ADHD children 
qualified for LD by using a narrowly defined method of inclusion. Other 
studies have found the percentage of ADHD children to qualify for LD closer to 
50%. Currently a diagnosis of ADHD does not qualify a child for any special 
services in school. A child with ADHD must concurrently have a specific 
learning disability to qualify. Cambell and Cohen (1990) found only 3 out of 51 
states provided special services for ADHD children who were experiencing 
academic underachievement. In 1976 (Federal Register) a law (PL 94-142) was 
passed which guides all services for special education. This law does not 
specifically mention ADHD as a qualifying disability, consequently many ADHD 
children do not get the school services they need. 
Kataria, Hall, Wong, and Keys ( 1992) compared ADHD children with and 
without learning disabilities and found that ADHD-LD children experienced 
more difficulty with information processing and transferring information 
from immediate to short-term or long-term memory, when the information 
was auditorily presented. Furthermore, they found a deficit in sequential 
processing. 
19 
ADHD children consistently make more errors in their school work than 
normal children (Sergeant & Van Der Meere, 1988). It seems that ADHD 
children fail to adjust their response speed when tasks become increasingly 
more difficult; therefore, when the material increases in difficulty, the 
number of errors made by the ADHD children increases dramatically 
(Sergeant & van der Meere, 1988). An important component for school success 
is to accurately assess one's own ability, and the degree of difficulty of the task 
to be undertaken. This seems to be a deficit for both LD and ADHD children. 
Feldman, Levine and Fenton (1986) compared ADHD children with normal 
children on their ability to accurately assess their performance on a number 
of tasks. The results of their study included the following important points: (a) 
ADHD children performed more poorly on two functional domains, rote 
memory and language comprehension, (b) there was a significant difference 
between the control group and ADHD group on estimating their own personal 
performance, (c) the ADHD subjects overestimated their performance or 
degree of success, which is what younger students typically do, ( d) there was a 
greater discrepancy between the predicted and actual performance for the 
clinic referred subjects, and (e) all subjects were able to more accurately 
predict their motor skills than their cognitive skills. 
Comparisons made between ADHD and normal children during effortful 
processing and memory tasks indicate that ADHD children have greater 
difficulty remembering new information because they are unable to integrate 
the new information into their existing schema (Ackerman, Anhalt, · Dykman & 
Holcomb, 1986). Ackerman et al. found that normal children improve memory 
skills if the words are related in some meaningful way, but ADHD children 
improved only slightly when the words were changed from unrelated to 
related. 
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Research indicates that there is a high degree of overlap between 
reading disabilities (RD) and ADHD (Levine, Busch & Aufsuser, 1982) and some 
researchers question whether they are distinct disorders or one common 
syndrome (Felton, Wood, Brown & Cambell, 1987). A group of more than 600 
children that were referred for academic problems were subsequently 
assessed as having primary attentional problems (Felton et al., 1987). A sample 
of ADHD children was assessed for information processing deficiencies, which 
is typically used to diagnose learning disabilities and 66% of them showed 
substantial deficits. Levine et al. (1982) compared ADHD only, with LD only, on 
several demographic and cognitive variables. The only differences between 
the groups included more behavior problems, and a higher incidence of 
language deficits including word finding problems among the ADHD children. 
Felton et al. (1987, p. 172) summarized the confusion about reading disabled 
children and attention deficit children, 
Thus the literature and common clinical experience agree: while RD and 
ADHD are not identical symptoms,. they do seem to overlap far more than 
would be expected from independent random distribution of these 
disorders. As a practical matter, this suggests that empirical 
characterization of either disorder is likely to be confounded by the 
presence of the other disorder. 
Torgeson ( 1985) summarized results of several studies and concluded 
that reading disabled children seem to have a primary deficit with encoding 
and retrieval of linguistic material. Torgeson elaborated by explaining that 
the primary difference between reading disabled children and normal 
children is a basic deficiency in accessing verbal information in long-term 
memory of the reading disabled children. Comparing RD and ADHD children 
yielded several distinct differences but about 50% overlap in the two groups 
(Felton, Wood, Brown & Cambell, 1987). 
Emotional Disturbance 
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"Comorbidity of ADHD with other behavioral and emotional disorders is 
generally quite common, with up to 44% having at least one other psychiatric 
disorder, 32% having two others, and 11 % having at least three disorders" 
(Barkley, 1990, p. 82). Breen and Barkley (1983) compared the average profile 
scores by using the Personality Inventory for Children. (PIC; Lachar, 1982; 
Wirt, Lachar, Klinedinst & Seat, 1987). They compared 26 ADHD children with 
26 normal children and the entire profile was about 20 T points higher for the 
ADHD children. ADHD children seemed to be at particular risk for affective 
problems such as depression and anxiety (Barkley, 1992b). Not only do more 
children meet the criteria for a diagnosis of anxiety, dysthymia and depression 
but those which do not meet the full criteria experience above average levels 
of affective problems (Barkley, 1990). It has been noted that ADHD children 
also have much greater somatic complaints compared to normal children 
(Barkley, Dupaul & Murray, 1990). 
Gottschalk and Gieser ( 1969) designed a test instrument to objectively 
measure the speech patterns of children on six scales of personality 
characteristics. Gottschalk, Swanson, Hoigaard-Martin, Gilbert and Fiore 
(1984) used the Gottschalk-Gieser content analysis scale to measure whether 
ADHD children differed from normal children in their speech patterns. 
Gottschalk et al. found that ADHD children scored significantly higher than 
the control group for cognitive impairment, social alienation-personal 
disorganization, and total depression. There were several subscales of 
depression in which the ADHD group was found to be significantly higher 
than the control group including: hopelessness, self-accusation and 
psychomotor retardation. 
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Studies that include adult ADHD subjects have found a very high 
incidence of long-term depression ( dysthymia) which has been present since 
childhood (Wender, Reimherr & Wood, 1981). Some of the overlapping 
symptoms that are commonly associated with both ADHD and dysthymia are 
poor concentration, problems sleeping, low self-esteem, psycho-motor 
agitation and mood instability. Jensen, Burke & Garfinkel (1988) wanted to 
assess the overlap and differences between major depressive disorder (MDD) 
and ADHD on several personality characteristics. They found that MDD was 
quite distinct from ADHD but a high percentage of the ADHD children 
exhibited significant signs of dysthymia. 
There is a higher than expected incidence of ADHD children with 
parents experiencing depression. Furthermore, among ADHD children there 
is higher than expected rate of depression in their first degree relatives 
(Biederman, Newcom & Sprich, 1991). Adopted children had a higher 
incidence of depression among their biological relatives than among their 
adoptive relatives and compared to a normal population. Biederman, Faraone, 
Keenan, Knee & Tsung (1990) posited that the same etiological genetic risk 
factors that contribute to ADHD problems also cause family members to be at 
high risk for depression as well. They hypothesize that the two genotypes of 
ADHD and depression share a common genotype. 
Fergusson and Horwood (1993) assessed the stability over a five year 
period of attention/hyperactivity problems and depression/anxiety problems. 
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They found both to be very stable based on the ratings of parents and teachers. 
During this five year period, they also found a correlation for 
attention/hyperactivity and depression/anxiety problems at between .35 and 
.31. They found slightly lower but significant correlation between 
conduct/oppositional behavior and depression/anxiety problems. 
Conduct or Behavioral Problems 
Probably one of the most consistent areas which ADHD children are 
deviant when compared to normal children is in their oppositional behavior 
(Barkley, 1990). More than 65% of the children referred to clinics for ADHD 
problems will also exhibit problems with oppositional behavior such as 
stubbornness, defiance, noncompliance, temper tantrums, and verbal hostility 
toward other people (Loney & Milich, 1982). Fergusson and Horwood (1993) 
found correlation of .84 to .80 over a five year period between 
attention/hyperactivity problems and conduct/ oppositional problems. 
Barkley et al. ( 1990) found that 21 to 45% of ADHD children and 44 to SO% of the 
ADHD adolescents will be diagnosed as having a serious problem of conduct 
sufficient to meet the criteria for Conduct Disorder (CD) as defined in the DSM 
III-R (APA, 1987). In the same study, they also found that up to 40% of the 
ADHD children and 65% of the ADHD adolescents will meet the criteria for 
Oppositional Defiant Disorder (ODD) (APA, 1987). There is such a significant 
overlap between ADHD and conduct problems that some researchers 
questioned whether they are actually distinct disorders. Recent research has 
indicated that there are many pure examples of both disorders, and there 
seems to be different correlates and outcomes for both disorders (Barkley, 
1990). Purely conduct disordered children will have a higher prevalence of 
psychiatric disorders among first level relatives than pure ADHD children and 
children with CD will also come from backgrounds with much higher degree 
of social adversity. ADHD children are more likely to exhibit developmental 
delays, and cognitive immaturities than CD children (Barkley, 1990). Those 
children that exhibit both ADHD and CD problems will present a complex and 
difficult pattern of behavior that is likely to be difficult· to successfully treat 
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Biederman et al. (1991) summarized the research comparing ADHD and 
CD cblldren. Family studies confirm that CD children are positively associated 
with parental antisocial behaviors and alcoholism but among ADHD children 
without CD, those factors do not occur at a higher rate than expected. ADHD 
children without CD are associated with academic and cognitive problems but 
CD children are not as significantly impaired (Biederman et al., 1990). 
Socia] Relationship Problems 
Breen and Barkley ( 1983) used the Personality Inventory for Children 
and found that mothers rated problems with social skills of their ADHD 
children 25 T points higher than did mothers of normal children. 
Furthermore, research indicates that more than 50% of ADHD children will 
have significant problems with peer relationships (cited in Barkley, Pelham & 
Bender, 1982). Many studies have found ADHD children to have a host of social 
problems, because they exhibit significantly more aggressive, disruptive, 
domineering, intrusive, and noisy behaviors. Clinical experience indicates 
that ADHD children show a marked deficit in reading social cues and seem to be 
oblivious to most of the subtle verbal and nonverbal communication patterns. 
It is not certain whether this is due to their impulsiveness or inattention but it 
is clear that ADHD children interact with their peers in a more hostile and 
combative way. ADHD children have been shown to have less knowledge of 
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social norms and what constitutes appropriate behavior with others (Grenell, 
Glass & Katz, 1987). 
Research that utilized direct observations of peer interactions of ADHD 
children, found they exhibit much more aggressive, disruptive, off-task, 
immature and provocative behaviors, and this elicits a pattern of controlling 
and directive behaviors from their peers in those circumstances in which 
they must work together (Clark, Cheyne, Cunningham & Siegel, 1988). 
ADHD children in general tend to have a greater external locus of 
control than normal children (Linn & Hodge, 1982). Locus of control involves 
viewing events that happened to them as being caused by forces outside of 
their personal control, such as luck or fate. Children with an external locus of 
control view school success or failure, behavior problems, etc. as outside their 
influence and therefore they are not likely to take steps toward solving a 
problem. 
Parent-Child Interaction Problems 
The multiple problems with conduct disturbance which ADHD children 
experience has previously been discussed. The oppositional behavior is most 
often carried out within the parent-child interactions and this creates 
significant stress in the relationship. It is important to understand the 
cybernetic principles (Danforth, Barkley & Stokes, 1991) of "systems theory" 
of family interactions. When looking at parent-child interactions a distorted 
picture will be presented if the problem is viewed from a linear position. 
Danforth et al. (1991, p. 704) wrote that "functional analysis of behavioral 
interactions show how behavior of one changes systematically according to 
the behavioral parameters of the other." It is important to remember that a 
key component in assessing a child's ADHD symptoms must always include 
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behaVioral elements. A child's behaVior does not occur within a vacuum or in 
isolation but within a family system. The importance of understanding the 
familial-social context when analyzing a child's behaVior cannot be 
overstated. Research consistently shows that interactions of ADHD children 
with their parents and siblings are quite different from that of normal 
children (Barkley, 1990). Another important facet to consider is that the 
families of ADHD children are more likely than normal children to experience 
psychiatric disorders and this is likely to place additional stress upon the 
family. 
Cunningham and Barkley (1979) performed important research to 
measure the interactions between mothers and their ADHD children, and 
compared it to the interactions. of normal children. They found that 
hyperactive children were "less compliant, more negative, more off task, and 
less able to sustain compliance than were normal children; in turn, their 
mothers were more commanding and negative, and less responsive to positive 
or neutral communications from their children than mothers of normal 
children" (cited in Barkley, 1990, p. 133). It was also shown that as the 
children matured and exhibited fewer behaVioral problems, the mothers 
changed their interactions with their ADHD children to be more positive. 
Despite the improvement, the ADHD parent-child interactions were far more 
conflictual than normals, even into adolescence. Research has consistently 
shown that when children are placed on medicine, their behaVior improves 
and the parent interactions with the child are more positive, supportive, and 
less intrusive (Barkley, 1990; Cunningham & Barkley, 1979). If we look at 
parents who have an ADHD child and compare how they interact with their 
ADHD child, and to their normal child, it becomes obvious the interactions are 
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qualitatively different. The ADHD parents interact with their non-ADHD 
children in typically normal ways but they interact with their ADHD children 
in negative, directive, punitive and impatient ways. 
Etiological Factors 
There is general agreement among the experts in this field that ADHD 
has many causes (Barkley, 1992). Initially, brain damage was believed to cause 
ADHD, but most of the children which exhibited ADHD symptoms had no 
history of brain damage. There are many factors which positively correlate 
with a higher incidence of ADHD, but care must be taken because correlation 
is quite different than causation. For example, there is a higher incidence of 
ADHD among children of mothers which smoke, but since ADHD adults are 
more likely to smoke, it is uncertain whether genetics or smoking is the key 
factor. "Our knowledge of the final common neurological pathway through 
which these factors produce their effects on behavior has been significantly 
increased by converging. lines of evidence from cerebral blood flow studies, 
studies of brain electrical activity using computer-averaging techniques, and 
studies using neuropsychological tests sensitive to frontal lobe dysfunction" 
(Barkley, 1990, p. 95). 
Researchers have found a number of birth related factors which occur 
more frequently for ADHD children than normals. These factors include: 
extended labor, premature delivery, young maternal age, toxemia, fetal 
distress, low birth weight, and low forceps delivery. Even though there is solid 
evidence for these neurological factors., they only account for about 5% of the 
total ADHD cases (Barkley, 1990). 
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The most solid empirically based evidence which differentiates ADHD 
adults from normal adults was conducted by Zametkin et al. (1990). They used a 
PET scan to measure brain activity and found that the ADHD adults showed 
significantly lower metabolism in certain parts of the brain. There has been 
an effort to identify neurotransmitter deficits in ADHD children. Some direct 
and indirect evidence has been found to support deficiencies in dopamine and 
norepinephrine (Shekim, Sinclair, Glasser, Horwitz; Javaid & Bylund, 1987; 
Barkley, 1990; Raskin, Shaywitz, Shaywitz, Anderson & Cohen, 1984; Lou, 
Henriksen, Bruhn, Bomer & Nielsen, 1989). 
The most consistent findings of several studies point to the central 
nervous system dysfunction as the cause of ADHD (Zametkin, 1988). The most 
likely area of dysfunction is in the connections between the prefrontal areas 
and the limbic system, especially in the stria tum (Zametkin & Rapoport, 1986). 
These areas of the brain are known to underlie response inhibition, 
inattention, and incentive learning or sensitivity to reinforcement (Barkley, 
1990). "They are also some of the most dopamine-rich areas of the humari 
brain, and so a hypothesis of selective dopamine depletion would be consistent 
with these other findings" (Barkley, 1990, p. 98). 
The area of greatest interest and that which provides the most 
compelling etiological argument for ADHD is genetic transmission (Barkley, 
1990). There have been many studies which confirm a higher incidence of 
ADHD in the biological relatives of children who have been diagnosed with 
ADHD. Many of the studies have been confounded with other disorders 
concurrent to ADHD such as CD, depression or anxiety. Other studies have used 
samples which were too small for good statistical reliability or validity. The 
most precise way to separate genetic contribution to any disorder is by 
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comparing monozygotic twins to see how high the concordance rate is for the 
twins. Two studies which compared identical twins found 100% concordance 
among the identical twins and one of the studies found 17% among the 
fraternal twins (Heffron, Martin, & Welsh, 1984; Lopez, 1965). Both studies 
used such small samples that care should be taken when interpreting the 
results. 
A much larger study was conducted by Goodman and Stevenson ( 1989) 
which compared 127 monozygotic twins and 111 dizygotic twins for 
hyperactivity. They found concordance among the monozygotic twins at 51 % 
and among the dizygotic twins at 33%. This study provides clear and 
unambiguous support that genetic contribution for ADHD is between 30 and 
50%. The most likely contribution that environment makes toward ADHD is 
between O and 30% (Barkley, 1990). 
Biederman, Faraone, Keenan, Knee and Tsuang (1990) assessed a group 
of children with ADHD, a control group ·and a group of children with a 
psychiatric disorder. They found among the relatives of children with ADHD, 
there was a diagnosis of ADHD in 25.1% of the relatives. This is compared to a 
control group which found 4.6% of their relatives had ADHD. The group of 
psychiatrically disordered children had a 5.3% rate of ADHD among their 
relatives, which did not differ significantly from the general population. 
Biederman et al. found the risk for the relative of an ADHD child, to also have 
ADHD was 7 .6 times greater than for the control group. About 64.8% of the 
ADHD probands had at least one relative with ADHD, compared to 15.4% of the 
controls. Among the ADD proband families, 44% of the fathers had ADHD, 
compared to 8% for the normals. It was also true for mothers, because 19% of 
the ADHD proband mothers had ADHD, compared to 0% for the normals. 
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Controlling for differences in SES, within the ADHD proband families yielded 
no significant differences between low, middle and upper income families 
regarding the incidence of ADHD. Biederman et al. concluded that "neither 
intactness of family nor high social class protected against familial risk for 
ADHD. In other words, the risk for ADHD among relatives of ADHD probands 
was as high in families with psychological advantage as in those with 
disadvantage." (p. 532). 
A study investigating behavior problems in biological relatives of boys 
with ADHD was conducted by Frick, Lahey, Christ, Loeber and Green (1991). 
They found that 20% of the mothers of ADHD children had ADHD, 36% had 
ADHD plus CD compared to. 11 % of the control group. Among the biological 
fathers; they found 40% had ADHD, 48% had ADHD plus CD compared to 22% of 
the controls. Both ADHD and CD disorders have a strong familial component, 
but they still seem to clearly have different familial patterns. 
Goldstein and Goldstein ( 1992) state that relatives of a child with ADHD 
are four times more likely than the general population to also have ADHD. The 
confounding variable in their finding is that relatives share common 
environmental and social factors as well as genetic factors. To separate the 
influence of the environmental factors, adoption studies supply valuable 
information. Goldstein et al. (1992) found that for adopted children their 
biological relatives were four times more likely than the general population to 
have ADHD. 
Russell Barkley, a leading expert in the field of ADHD research, (1990) 
summarized his conclusions regarding the etiology of ADHD. 
Most investigators in this area endorse a biological predisposition to the 
disorder; much like that of mental retardation, in which a variety of 
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neurological etiologies ( e.g., pregnancy and birth complications, 
acquired brain damage, toxins, infections, and heredity) can give rise to 
the disorder through some disturbance in a final common pathway in 
the nervous system. In the case of ADHD, it would seem that heredity 
factors play the largest role in the occurrence of these symptoms in 
children. It may be that what is transmitted genetically is a tendency 
toward dopamine depletion in, or at least underactivity of, the 
prefrontal-striatal-limbic regions and their rich interconnections. The 
condition can be exacerbated by pregnancy complications, exposure to 
toxins, or neurological disease, and by social factors (such as 
environmental and family adversity, dysfunctional child rearing and 
management or educational environment). Cases of ADHD can also arise 
without a genetic predisposition to the disorder, provided the child is 
exposed to significant disruption or neurological injury to this final 
common neurological pathway; however, this would seem to account for 
a small minority of ADHD · children. By contrast, little evidence supports 
the notion that ADHD can arise purely out of social or environmental 
factors, such as poverty, family chaos, diet, or poor parent management 
of children (p. 104-105). 
Psychopharmacologkal Treatment 
In order to provide effective treatment, it is vitally important to have a 
dear understanding of the nature and etiology of ADHD. Great pains have 
been taken in the present study, to clearly lay a path which will provide for 
the reader a map for effective treatment. The treatment of ADHD children is 
probably more controversial than any other area of the disorder. Many times 
the treatments have not been based upon empirical or theoretical 
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underpinnings and the treatment research is confusing and does not provide 
consistent answers. This is primarily because of poor research design due to 
small samples, poorly selected treatment groups, lack of a control group, and 
in general, not controlling nuisance variables. The treatment area which will 
be reviewed in this study is focused upon medication. 
The use of medicine for the treatment of ADHD children has been 
criticized and has come under attack from groups which profess to represent 
children's rights. The whole subject of the psychopharmacological treatment 
of children is complex and is influenced by many factors. The use of 
psychopharmacological treatments for children is still so new that there is a 
noticeable absence of long-term studies (Barkley, 1991b). There are two 
primary groups of medication which are typically used for the treatment of 
ADHD children: stimulants and antidepressants. (Biederman & Steingard, 1989). 
In addition, there are some medications which are used infrequently such 
antihypertensives, antipsychotic and anorectic medications. The individual 
chemistry of each child will d,etermine which medicine works most 
effectively, as well as the side effects each of the medications might cause. 
Another factor that will impact which specific medicine works most 
effectively in treating ADHD is the existence of others disorders such as 
anxiety, depression, conduct disorder or Tourette's. 
Stimulant Medication 
Stimulant medication and specifically methylphenidate (MPH) is the 
most commonly prescribed psychotropic treatment for children in the United 
States . Since 1983 there have more than 900 research articles written about 
the use of stimulant medication for the treatment. of ADHD (Wilens & 
Biederman, 1992). It is probably the most researched type of medication of any 
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kind, yet the use of stimulants for ADHD children remains controversial and it 
still faces intense opposition. The opposition has vehemently criticized giving 
children medication even though the scientific research demonstrates 
unequivocally the safety and efficacy of their use (Wilens & Biederman, 1992). 
Wilens and Biederman reviewed over 230 studies which evaluated the efficacy 
of stimulant medication for children of all ages and concluded that 65-75% of 
the children respond favorably. Other scientists have found a success rate for 
MPH at around 75%, when judged by teachers rating scales (Greenhill, 1992; 
Forness, Cantwell, Youpa & Hanna, 1992) .. 
Historically, the first documented use of stimulant medication for 
children is attributed to Charles Bradley in 1937 (Barkley, 1990; Wilens & 
Biederman, 1992; Weiss & Hechtman, 1993). He used amphetamines to treat 
children who were hospitalized for behavior problems and they experienced 
rapid improvements in both their behavior and school performance. There 
was not any further mention in the literature of stimulant medicine until the 
late 1950's when it seems the scientists rediscovered Bradley's work. The 
increased interest may have coincided with the commercial release of Ritalin 
in 1957. 
Safer and Krager (1988) conducted a comprehensive review of the ADHD 
research and found that by 1987 about 6% of the elementary school age 
children were taking stimulant medication which amounted to 1.6 million 
children. They also found that every four to seven years the rate of children 
being medicated for ADHD doubles. During the time from 1980 until 198 7, the 
use of stimulant medication increased from 76% to 90% of the total medicine 
prescribed for ADHD. During this same time, MPH comprised more than 93% of 
the total stimulant market (Wilens & Biederman, 1992). 
Stimulants get their name from the arousing effect they have on the 
central nervous system (CNS). It is believed that stimulants have multiple 
effects on the chemistry of the brain. In some cases they increase the 
production of neurotransmitters and in other cases, they slow down the re-
uptake of the unused neurotransmitters at the synaptic cleft, which 
effectively makes more available (Wilens & Biederman, 1992). It is still not 
clearly understood just how stimulants do their work, but it is hypothesized 
that they work primarily on dopamine and norepinephrine levels and to a 
lesser extent serotonin. 
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Most effective drugs alter both noradrenergic and dopaminergic 
neurochemical systems, but in different ways. It is becoming cle~r that 
neurochemical systems do not function in isolation, and therefore no 
drug is absolutely specific in its effects on one neurotransmitter. Given 
the growing list of agents efficacious in treatment and their 
biochemical heterogeneity, single neurotransmitter hypotheses appear 
untenable at this time; however, dopamine and norepinephrine are 
clearly involved (Zametkin & Borcherding, 1989, p.449). 
There are three primary types of stimulant medications used for ADHD 
children: d-amphetamine (Dexedrine), methylphenidate (MPH; Ritalin) and 
pemoline (Cylert). Ritalin is used in 90% of the cases where stimulant 
medicine is prescribed (Wilens & Biederman, 1992). Dexedrine and Ritalin are 
chemically very closely related and act in the same basic way within the body. 
Cylert is much the same in its effects but is quite different in chemical 
structure from the other two. Cylert tends to last longer than Dexedrine or 
Ritalin but does not produce its positive effects nearly as quickly (Barkley, 
1990). It is not clearly understood how psychostimulants perform their work 
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but animal studies provide support for the theory that "the absorption phase 
parallels the acute release of neurotransmitters into synaptic clefts, providing 
support for the hypothesis that alteration of monoaminergic transmission in 
critical brain regions may be the basis for stimulant action in ADHD" (Wilens 
& Biederman, 1992, p. 193). There are many theories as to what region of the 
brain the stimulants work, but recent research seems to indicate that it 
increases the activity level and blood flow of the striatum and the connections 
between the orbital-frontal and limbic regions (Barkley, 1990). 
The most popular brand of MPH is Ritalin and is manufactured by Ciba-
Geigy. Ritalin is available as an oral dosage in the following tablet sizes: 5 mg, 
10 mg, 20 mg and SR 20 mg (slow-release version). It is typically taken daily, 
in the morning and noon, and some children take a half dose after school. The 
dosage range of Ritalin is from 2.5 mg to 25 mg. per day (Greenhill, 1992). A 
primary reason why Ritalin is so popular is the short half-life it has in the 
body, which is typically between 2 and 4 hours. "MPH is metabolized rapidly 
because it is not highly bound to plasma protein, nor does it disappear into fat 
stores" (Greenhill, 1992, p. 7). Because MPH is metabolized so quickly in the 
body, its impact on symptom improvement is usually not more than 4-5 hours, 
with the peak benefits being at about two hours (Barkley, 1990) MPH is not 
easily monitored in the child's body because it is used in such small quantities 
and because it rapidly disappears from the plasma. This prevents the use of 
physiological monitoring to determine the most therapeutically effective 
levels within the child, and forces a lot of guessing in order to adjust dosages to 
their proper levels. 
MPH is one of the safest medications used in the treatment of children, 
with a 100:1 margin of safety (Greenhill, 1992). MPH has minimal potential for 
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abuse, and the addiction liability is quite low because it does not provide any 
noticeable euphoria (Wilens & Biederman, 1992; Greenhill, 1992). MPH is 
preferred over its cousin Dexedrine for several reasons. First, it produces less 
euphoric mood elevation; therefore, it seems to provide a smaller risk for 
addiction. Second, it is used in the majority of the research because it is quick-
acting, has a short half life, provides noticeable improvement on global 
behavior rating forms and has minimal side effects (Greenhill, 1992). Since 
there is so much research to support its use, clinicians feel safer in 
prescribing it. 
Even though MPH is considered very safe, it still has some potential side 
effects. The most common side effects which are mentioned in clinics include: 
insomnia, decreased appetite, weight loss, headaches, heart rate elevation at 
rest, minor increases in systolic blood pressure, dizziness, irritability, growth 
impairment, dysphoria, rebound, and increased crying (Greenhill, 1992; 
Wilens & Biederman, 1992). Most of the time, the side effects are minor and 
can be managed by altering the time when the medicine is taken or changing 
the dosage rate. Sometimes it becomes necessary to stop the medicine for a few 
weeks and then start it again, which can alleviate the side effects when the 
medicine is re-instituted. There is some evidence that mentally retarded 
children experience more side effects than children of average intelligence 
(Handen, Feldman, Gosling, Breaux & McAuliffe, 1991). Handen et al. assessed 
ADHD children with IQs between 48 and 7 4 and found a higher incidence of 
motor tics and social withdrawal, and concluded that mentally retarded ADHD 
children may present a higher risk than non retarded children for side 
effects. 
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Rebound is one of the most common side effects mentioned through 
clinical lore but there has been very little empirical investigation of rebound. 
Rebound effects are defined as a "deterioration in behavior that occurs in the 
late afternoon and evening following daytime administrations of medication. 
This deterioration is said to exceed that expected from baseline or placebo 
levels of behavior" (Johnston, Pelham, Hoza & Sturges, 1988, p. 806). Johnston 
et al. measured the evening behavior of latency aged boys after taking a 
placebo some days and MPH other days. They found only slight differences in 
the parent ratings between the placebo and two different dose levels of MPH. 
There was so much variation within the groups, that the statistical 
significance was found on only one measure. The data indicates that rebound 
for the majority of children is neither large nor clinically significant and in 
no cases was it high enough to alter the dosage rate. 
Another side-effect of stimulant medication which is listed in the 
literature (Robbins & Sahakian, 1979; Swanson, Kinsboume, Roberts & Zucker, 
1978) is over-focusing. The term over-focusing is defined in the following 
way: (a) decreased ability to shift mental state, (b) repeated scanning of a 
restricted domain of stimuli without improving performance, (c) difficulty 
with divergent thinking, and (d) the emergence of tics or other stereotypic 
behavior (Tannock, Schachar & Logan, 1993). The problems encountered with 
over-focusing are usually related to high levels of MPH and there are no 
incidences of over-focusing using normal therapeutic dosages. Tannock et al. 
studied the effects of two doses (.3 & 1.0 mg/kg) of MPH onADHD children by 
using a cued reaction time paradigm. They found that stimulant effects on 
focused attention are dose-dependent and time-dependent but they did not find 
any indication of over-focusing. The MPH improved attention only at the 1.0 
dosage rate and it was not significant until 2.5 hours after the medicine was 
taken. 
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A potential non physiological side-effect of MPH is in the area of 
attribution. Exactly what "message" a child gets when he/she takes medicine 
to improve his/her behavior is a question asked by many scientists (Whalen & 
Henker, 1991b). Some children and parents view the use of medication as a 
"magic pill" which gives all the credit to the medicine and removes any 
responsibility or credit for the improvement from the child. It is not the focus 
of this study, but for many years it has been consistently shown that an 
external attributional belief system will place a person at higher risk for 
many social, academic and behavioral problems (Whalen & Henker, 1991a). 
Pelham et al. (1992) performed two studies trying to assess the attributional 
attitudes of ADHD children who were taking medication. They found in the 
both studies that ADHD children who were effectively helped by medicine 
attributed the improvement to their own effort and when it did not work, they 
blamed the failure on the medicine or to counselors. Carefully setting realistic 
expectations needs to be done when medication is instituted, so that medication 
is seen in a more realistic context. Both parents and children need to view the 
medicine as a helper for the child to accomplish what he/she want to do but 
previously has been unable to do. 
Motor or vocal tics are not a common side-effect but are worth 
mentioning because of their severe nature. About 1% of the children who take 
stimulant medication will develop tics (Gadow & Sverd, 1990). Most all cases of 
tic development can be reversed upon cessation of the medication. There tends 
to be an exacerbation of existing tics when stimulant medication is 
implemented; however, there is an almost equal number of children taking 
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MPH who have a lessening of tics. Gadow and Sverd assess the relative risk of 
all medication which is typically given for ADHD treatment and conclude that 
the relative risk of using stimulants is · comparable to antidepressants and 
neuroleptics, especially when the risk of all side-effects is considered. 
Exactly which primary area of behavioral disturbance in the ADHD 
child is most problematic will impact the pharmacological decisions. Many 
studies have concluded that the optimum dosage of MPH should be determined 
by which area of disturbance is of primary importance. Several studies have 
found that the optimum cognitive dosage rate is lower than the optimum social 
dosage (Barkley, 1990). Each of the ADHD symptoms are not treated optimally 
by medicine at the same dosage rate; therefore, it should always be recognized 
that what is most effective for group treatment is highly variable when it is 
applied to an individual case. Some doctors calibrate their dosage based upon 
the size of the child (mg/kg), while others use an absolute dosage rate 
(Greenhill, 1992). People who try to predict the particular response of each 
child based upon any formula will fmd it an elusive adventure. 
The physiological side effects of MPH have been researched sparingly. 
The primary findings of this research is that MPH may slow down the rate of 
growth slightly, but does not have any long term inhibition on growth 
(Barkley, 1990). It is not known exactly how it might effect growth, but the 
most likely reason for suppression of weight gain is the reduced caloric 
intake, which has been supported by research. A few studies have proposed 
an increase in the systolic and diastolic blood pressure but there are so many 
factors which influences blood pressure, that no unambiguous evidence exists 
for this increase (Barkley, 1990). Barkley theorized after studying the 
literature that MPH does heighten the background electrical activity of the 
CNS and it seems to heighten the excitatory brain mechanisms. 
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More than ten years ago, Barkley and Cunningham (1978) reviewed the 
literature on the effetts of MPH on academic performance. It was clear from 
their review that classroom behavior was significantly improved but there did 
not seem to be an improvement in academic performance or learning in any 
measurable way. In particuiar, researchers have been puzzled as to why there 
is a lack of improvement on standardized tests after taking stimulant 
medication (Brown, Jaffe, Silverstein & Magee, 1991). Some have hypothesized 
that subject compliance with dosages may explain part of the discrepancy 
(Brown, Borden, Wynne, Spunt & Clingerman, 1987), while others indicate that 
the problem is the brief intervention periods between medication and 
measurement (Brown et al., 1991). Another criticism of previous findings is 
that the academic achievements are not sufficiently sensitive to detect the 
changes over such a short period of time (Brown et al., 1991). More recent 
scientists have taken exception to the early research conclusions that MPH 
does not improve academic achievement (Swanson, Cantwell, Lerner, 
McBurnett & Hanna, 1991). Swanson et al. posits that the early research design 
had several flaws such as poorly defined groups, small samples, not 
controlling for comorbid disorders such as learning disabilities, and failure to 
titrate the dosage until the most effective rate was achieved. More recent 
studies show improvements in academic achievement between 25% and 40% 
after taking MPH (Swanson et al., 1991). 
Swanson et al. ( 1991) wanted to investigate the effects of MPH on 
learning and concluded that the question was too complex for a simple yes or 
no answer. Some areas of learning and academic performance seemed to be 
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helped more than others and in different studies, different types of academic 
performance are improved by medication (Pelham, Vodde-Hamilton, Murphy, 
Greenstein & Vallano, 1991). A significant problem in assessing the most 
effective dosage is that cognitive improvement seems to be maximized at lower 
doses than behavioral maximized doses. In fact, the higher rate of dosage 
which maximizes behavioral problems may have a negative effect on learning 
(Brown, Jaffe, Silverstein & Magee, 1991) but it is usually the behavioral issues 
which bring the client in for treatment and therefore the motivation is 
stronger for emphasizing this area. Another problem in researching the 
effects of MPH on learning is that each subject has a dosage level which is 
most effective and when dosage rates are controlled by group membership, 
there will be a high degree of within group variance. The third problem 
which Swanson et al. discusses is that a certain number of subjects will be 
non-responders to medicine and this will confound the results of any tests, 
because the non-responders will under estimate the treatment effectiveness of 
MPH. 
Carlson, Pelham, Swanson and Wagner ( 1991) studied the effects of MPH 
on arithmetic performance of ADHD grade school age males and found that 
MPH improves arithmetic performance of ADHD children. The children not 
only solved more problems accurately, but also spent less time solving the 
problem and moved on to the next problem more quickly. This study supports 
the idea that faster performance of children while on medication is a factor of 
both decreased time answering the problems and also being able to focus more 
effectively in order to move on to the next problem. Carlson et al. posits that 
rather than an increase in overall attention, the MPH allowed the subjects to 
allocate the existing attention more efficiently. 
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Brown, Jaffe, Silverstein and Magee (1991) looked at the effect of MPH 
on ADHD adolescents with conduct disorder. They compared the academic 
performance, behavior in the classroom and impulsivity of adolescents before 
and after taking medication. They also compared pure CD and ADHD plus CD; 
for all of the measures previously mentioned. Some of the significant findings 
of their study include: (a) that MPH significantly improved arithmetic 
performance with an effect size of .91, (b) adolescents with pure CD improved 
both their classroom behavior and arithmetic performance by taking MPH, (c) 
the doses for maximum school improvement were 10 mg, while the doses for 
maximum behavior improvement were 20 mg., and (d) overall, the CD 
adolescents showed improvement at higher doses than the CD + ADHD 
adolescents. 
To answer the criticism of previous studies, Forness, Swanson, Cantwell, 
Youpa and Hanna (1992) designed a study to examine the effects of sustained 
treatment as opposed to short-term treatment with MPH. They controlled for 
the presence of learning disabilities, and conduct or oppositional disorder and 
used reading performance as the dependent variable. They also screened out 
drug non-responders and prior to treatment, they determined the most 
effective dosage for each subject. Comparisons were made for pure ADHD, and 
mixed ADHD/CD or ODD on several cognitive pre-treatment measures, and the 
only measure which was significant was for reading comprehension in which 
the mixed disorder group performed more poorly. They measured two types of 
reading skills: reading fluency and reading comprehension. The results of the 
study found that only the mixed ADHD group significantly improved their 
reading performance on reading comprehension. This was probably due in 
part to their low pre-treatment scores on reading comprehension which 
allowed them more room for improvement. The authors speculated that the 
combination of ADHD and conduct disorder worked additively to diminish 
concentration on a more complex task such as reading comprehension. It 
seems that experiencing both attentional problems and environmental 
adversity, work in combination to place the ADHD child with a mixed 
behavioral disorder at greater risk for reading problems. 
The belief that mentally retarded children would not respond 
43 
effectively to MPH has been in the clinical lore for years but there have been 
few studies to empirically assess its validity. A recent study was designed to 
answer some of the questions about the efficacy of stimulant medication for 
mentally retarded ( 48 to 7 4 IQ) children who also had ADHD (Handen, Breaux, 
Janosky, McAuliffe, Feldman & Gosling, 1992). Handen et al. found significant 
improvement in on-task behavior and attentional skills when compared to the 
placebo; however, they found no improvement on learning or social 
interactions. Based upon. this study and previous work by the same authors, 
they concluded that mentally retarded children respond (64%) to medication at 
about the same rate as non retarded children. The lack of improvement in 
learning and academic tasks is probably indicative of intellectual limitations 
rather than attentional problems from ADHD. 
Barkley (1988) measured the interactions between hyperactive 
preschool children and their mothers to see how the use of Ritalin would 
effect the high level of conflict which they typically experience. He placed 
the children on two levels of Ritalin (.15 mg/kg and .5 mg/kg) and compared 
the interactions between the ADHD preschoolers and their mothers. He found 
that ADHD children did not have significant behavioral problems in free play 
situations. It was only when demands and restrictions were placed upon the 
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children that their behavior became deviant. He found that when the 
preschoolers were placed on MPH, as compared to the placebo, the mothers 
were more positive and supportive in their interactions with the children. As 
the children's compliance increased, the mothers responded by less 
controlling behavior, fewer criticisms and more compliments. There are a 
number of studies which have found these same results in older children, but 
this is the first to measure preschool children. It has previously been 
proposed that children under the age of six will not respond to stimulant 
medication, but in this study Barkley found that children between the ages of 
2.5 and four years of age, do respond positively to medication. 
There seems to be two universal truths regarding the social interactions 
of ADHD children. The first is that the vast majority of ADHD children will 
have serious social problems that are pervasive in all areas of their lives and 
that they experience a high level of conflict and confrontation. Secondly, 
their social problems exhibit a high level of variability in both form, as well 
as intensity (Whalen & Henker, 1991a). There are various explanations as to 
whether the social problems are due to limitations of ability or of application. 
Whalen and Henker propose a possible social learning disability much like 
academic learning disabilities in which the ADHD child lacks the ability to 
master "the subtle yet perceptual decoding, enactment, self-monitoring, and 
fine-tuning required for effective interpersonal exchange" (p. 231). One 
thing is for certain, that aggressive behavior is the main source of peer 
problems and that ADHD children and adolescents are more aggressive in their 
interactions (Hinshaw, 1991). 
Probably the most readily identifiable social problem which ADHD 
children experience is an elevated level of disruptive behavior and conflictual 
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peer exchanges (Whalen & Henk.er, 1991a). This disruptive behavior is the 
area in which stimulant medication most effectively produces improvement 
(Abikoff & Gittelman, 1985). Abikoff and Gittelman found that ADHD children 
treated with MPH became indistinguishable from normal children in their 
rates of noncompliance, interference, and demands upon the teachers 
attention. All of these areas were significantly higher for the ADHD children 
prior to medication. During unstructured play time, the ADHD children do not 
differ from normal children significantly and therefore medication does not 
have as much impact on improvement of behavior during this time. The 
noticeable improvements occur during structured play time where there are 
rules and complicated social interactions demanded (Whalen, Renker, Collins, 
McAuliffe & Vaux, 1979). 
Pelham et al. (1990) designed a significant study comparing ADHD 
children's behavior during baseball drills and games. They found that the 
actual physical skills (hitting and catching) did not seem to change but there 
was a marked improvement in their ability to attend to and follow the game. 
Their teammates were more accepting and forgiving of their physical 
limitations but tended to be much more critical of any mistake made while not 
attending to the game. This study seems to indicate that important secondary 
gain can take place from medication involving social interactions. 
The reduction of negative behavior after taking stimulant medication is 
well documented but there is little support in the literature for the acquisition 
of positive behavior. Whalen, Henk.er, Buhrmester, Hinshaw, Huber and Laski 
(1989) studied a group of ADHD and normal boys in a summer school program. 
The ADHD boys placed on medication were more likely to be named "best 
friend" and nominated as "fun to be with and cooperative" by the other 
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children. The improvement seemed to be dose .related because the most 
improvement took place on the highest dose rate. Whalen and Renker (1991a) 
reviewed the study and concluded that, "An uncooperative classmate not only 
interferes with or disrupts a child's ongoing activities, but he also may get the 
other kids in trouble, perhaps by preventing task completion or eliciting 
negative group sanctions from the teacher." (p. 233) Whalen and Renker also 
concluded from the study that stopping the negative interactions of the ADHD 
children most definitely made for better peer relations but did not immediately 
give them the needed skills to build lasting relationships. They concluded, 
"Medication appears to reduce the abrasiveness of social intercourse- the 
disruptive or domineering demeanor of the child with ADHD. Medication 
cannot, however, be expected to spawn social competence, sensitivity, and 
support- qualities that allow children to interact amicably and cultivate 
chumships." (p. 234) Another study compared medicine versus placebo for 
ADHD children and adolescents. They found significant improvements for the 
children using MPH in their peer interactions; however, the adolescents did 
. . 
not improve their peer interactions when using MPH (Pelham, Vodde-
Hamilton, Murphy, Greenstein & Vallano, 1991). The lack of improvement for 
adolescent peer relations may be due to changes in the way adolescents 
interact. In particular, adolescents don't view cooperation and compliance as 
positive attributes and peer pressure may override any positive effects which 
the medication could provide. 
Whalen and Renker ·(1991) compared ADHD children on medicine with 
those on a placebo on a ~elf-perceived anger scale. They found that the ADHD 
children taking the placebo experienced significantly higher scores in self-
perceived anger compared to the children taking medication. The ones that 
47 
started out on the placebo and then were placed on medication had a 
significant decline in self-perceived anger. Hinshaw (1991) reviewed several 
research articles regarding the effects of MPH on aggression in children with 
attention problems. Aggression is complex and multidimensional construct; 
therefore, it is difficult to measure precisely and accurately. It is common for 
children to show their aggressive behavior in some settings or with some 
people but not with others. One study compared normal, ADHD/nonaggressive 
and ADHD/aggressive children for acts of aggression toward peers (Hinshaw, 
Henker, Whalen, Erhardt & Dunnington, 1989). The mixed ADHD/aggressive 
group started out with more than four times the rate of aggression, while the 
pure ADHD group was the same as the control group. There was a significant 
drop in aggression when a dosage rate of .3 mg/kg was used, but the rate of .6 
mg/kg moved the ADHD/aggression group to norm.al levels of aggression. The 
results are consistent with previously cited studies, that higher dose rates are 
needed for maximum improvement in aggressive and disruptive behavior. 
There has been lengthy debate over what effect MPH has on the 
affective state of ADHD children. Recent studies have revealed a more flat 
affect with children taking MPH compared to a placebo (Whalen, Renker, 
Hinshaw & Granger, 1989). There are still too many unanswered questions to 
draw any conclusions regarding how MPH alters the mood of children and 
there is no conclusive evidence as to how the potential dysphoria impacts the 
social interactions of ADHD children. It is also not known whether reduced 
interactions will necessarily impact social interactions negatively. A 
dysphoric mood could allow the ADHD children to reflect on social cues and 
observe prosocial activities of others; conversely, it may deny the ADHD 
children learning opportunities obtained from interacting with their peers 
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(Whalen & Henk.er, 1991a). Additional work needs to be done in this area to 
answer these questions. The use of stimulant medication is effective in 
between 65% and 75% of the ADHD children (Safer & Krager, 1988). Stimulants 
comprise about 90% of total medicine used for ADHD children, with MPH 
comprising about 93% of the total stimulant market (Wilens & Biederman, 
1992). 
There are still a substantial number of children who don't respond to 
stimulants or who have too many side-effects to continue their use. 
Antidepressants are typically the second choice for treating ADHD children. 
Barkley (1990) states that 70% of the children who do not respond to 
stimulants, will respond favorably to some type of antidepressant. 
Antidepressants are slower-acting but have been shown to produce similar 
behavioral benefits for ADHD children. The use of stimulants is. usually 
focused on the learning schedule and involves medication only during the 
time when the children are at school. This can lead to problems at home 
because when the child goes back to baseline levels of behavior, and in some 
cases may experience rebound, then he/ she will frequently behave badly at 
home. Antidepressants may be the preferred medication when there is a 
significantly higher incidence of behavior problems at home, than at school 
because antidepressants typically last 24 hours per dose (Barrickman, Noyes, 
Kuperman, Schumacher & Verda, 1991). Another factor which increases the 
efficacy of using antidepressants for ADHD children is the comorbidity of 
depression. As previously discussed, ADHD children have a higher than 
normal incidence of depression and their relatives also have a higher than 
expected rate of depression. Stimulant medication can exacerbate the 
depression in an ADHD child because of its sedating effects. The use of 
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antidepressants for children began with the treatment of ADHD children and 
only recently have they been used for the treatment of depressed children, 
(Pliszka, 1991). In fact, it is only in the most recent history, that childhood 
depression has even been recognized and treated. The rate of effectiveness of 
antidepressants for the treatment of depression is between 30% and 95%, based 
on a review of the literature by Pliszka. The effectiveness improves 
significantly when plasma levels are monitored in order to obtain the 
maximum therapeutic range. A note of warning should be voiced regarding a 
higher risk of heart problems with children who use antidepressants. There 
have been three incidences reported in the literature recently of children 
who died from heart problems, and who were taking antidepressants, (Pliszka, 
1991). A careful screening should be conducted on children who have a 
history of heart problems or any child with a high family prevalence of heart 
problems. 
Antidepressants 
The use of antidepressants have consistently been found to be less 
effective in the treatment of ADHD than stimulants; however, they have also 
been found to be consistently more effective in the treatment of ADHD when 
compared to a placebo (Pliszka, 1991 ). The two most common antidepressants 
used for the treatment of ADHD in children are Desipramine and Imipramine. 
They both seem to work effectively and have the fewest side-effect (Pliszka, 
1991). Recent studies have found Desipramine to be more efficacious than 
Imipramine for the treatment of ADHD, and seems to have fewer side effects 
(Barkley, 1990). Both medications have been found to be effective in the 
improvement of inattention, impulsivity, hyperactivity and aggression, but 
neither has shown improvement in cognitive functioning such as on a 
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Continuous Performance Test. Barkley wrote that for children with severe 
aggression problems, Imipramine may make their behavior worse, if exposed 
to long-term treatment. A newer antidepressant which looks promising as an 
alternative for ADHD treatment, especially for those children with high levels 
of depression is Fluoxetine (Prozac). Fluoxetine has been very effective in the 
treatment of depression, especially in adults, but Barrickman, Noyes, 
Kuperman, Schumacher and Verda (1991) were the first to investigate the use 
of Fluoxetine for ADHD children. They did not control · for depression among 
their subjects but their was a 42% rate of affective disorders among first-
degree relatives of the subjects in their study. They found that 60% of their 
sample of children and adolescents with ADHD were judged to be moderately 
improved in their behavioral symptoms. There was no effect on appetite or 
weight gain, which is a common side-effect for tricyclic antidepressants. 
Riddle, Hardin, Soo, Woolston & Leckman (1988) found Desipramine to be 
an effective alternative for ADHD children who experience tic disorders or 
have a family history of tics disorders. They found that 71 % of the subjects 
improved their global behavior ratings and there was not an increase in the 
incidence of tic symptoms. 
In summary, the most compelling reason for using tricyclic 
antidepressants for the treatment of ADHD are the following: (a) children who 
don't respond to stimulants, (b) children who exhibit marked signs of 
depressions or anxiety, (c) children who develop tic disorders when they 
begin taking stimulants (Riddle et al., 1988), (d) children or adolescents who 
have a history of substance abuse (Barkley, 1990), (e) children who suffer 
from insomnia or nocturnal enuresis because this can be exacerbated by 
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stimulants (Hilton et al., 1991) and (f) children with no prior history of heart 
problems (Pliszka, 1991). 
MisceHaneous Medications 
There are a few other medications which do not fit into a single 
category but include antihypertehsives., specifically Clonidine (Barkley, 1992), 
neuroleptics, such as thiordazine (Klein, 1991) and anorectics, such as 
fenflurafin (Aman, Kem, McGhee & Arnold, 1993) The use of Clonidine for 
ADHD is very recent even though it has been used for many years quite safely 
to treat high blood pressure. Clonidine is "thought to be an alpha-
noradrenergic agonist acting on the presynaptic neurons to inhibit 
endogenous release of norepinephrine in the brain" (Weiss & Hechtman, 1992, 
p. 364). Clonidine has been shown to be effective in lowering the 
hyperactivity and impulsiveness, as well as decreasing aggressive behavior. 
It has not been found to be effective in helping children with their attention 
problems or improve their productivity in school, but it does provide a 
valuable alternative for some children. Hunt, Capper and O'Connell ( 1990) 
found Clonidine to be especially effective with children who have CD or ODD 
because it seems to especially effective with aggressive children and 
adolescents. Hunt et al. advocated the use of Clonidine and MPH together for 
children with conduct disorder or who have tic disorders because the MPH can 
be reduced by 40% when used in combination with Clonidine. It is possible 
that as additional research provides more accurate guidelines for the most 
effective dosage rates, Clonidine will prove to be even more useful. 
The use of neuroleptics to treat hyperactive children has been reported 
by several investigators (Klein, 1993); however, it is controversial because of 
the concern for its possible deleterious effect on the cognitive functioning of 
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children; Klein (1993) used thioridazine to treat a group of ADHD children and 
measured its effect on their cognitive functioning. She found that the 
children stayed the same on thioridazine compared to placebo for all cognitive 
functioning except sequential processing, which went down significantly 
when the children were given thioridazine. 
Fenfluramine typically is used to treat obesity but has a depressive 
effect on the central nervous system compared to stimulants, which are also 
used for weight control but have an increase on the level of activity of the 
central nervous system. Fenfluramine has previously been used to treat 
autism in children and seems to have serotonin reducing effect on the blood 
levels of children. It was theorized by Aman, Kem, McGhee and Arnold ( 1993) 
that Fenfluramin might be more effective in treating core symptoms of ADHD 
children who are also mentally retarded. Aman et al. used mentally retarded 
subjects in their study and found significant improvement in conduct 
problems, inattention and hyperactivity when· compared to the placebo. 
Overall, the behavior ratings given by· the teachers were improved to a 
greater extent than the parent behavior ratings. 
Meta -Analysis 
The first person to use the term "meta-analysis" was Gene Glass in 1976, 
at his presidential address to the annual meeting of the American Education 
Research Association (Hedges, 1987). Gene Glass defined meta-analysis as "the 
statistical analysis of a large collection of analyses results from individual 
studies for the purpose of integrating the findings" (Glass, 1976, p. 3). Since 
1976, there have been literally hundreds of meta-analyses conducted and 
reported in the scientific journals. Disagreements about meta-analysis 
53 
revolve around many of the same issues which have been expressed for years 
between the relative value of quantitative versus qualitative research in 
general (Hedges, 1987). Hedges posits that this type debate obscures the real 
contributions which meta-analysis has made. He explains that the most 
significant contribution of meta-analysis to the field of research is an 
increased focus on the issue of methodological rigor in research reviewing. It 
has led to serious examination of methodological standards in research 
reviewing and impressed upon scientists the need to improve the standards. 
Rigorous methodological standards work to insure the validity of 
research. Standards exist because it is commonly known that biases exists in 
which procedures will render the results either invalid or uninterpretable. 
Some of the areas which are potentially influenced by bias include: problem 
formulation, data collection, data evaluation, data analysis, and reporting of 
data (Hedges, 1987). Efforts to standardize these procedures are conducted in 
order to control biases and improve the validity and reliability of original 
research. The general increas.e in concern for the use of rigorous 
methodology is viewed as progress, even by those who are critics of meta-
analysis. Some specific contributions which meta-analysis has made are listed 
by Hedges. First, meta-analysis has increased the concern about data 
collection in research reviews and has emphasized the need for rigorous 
control of the sampling activity of which studies to include in a review, and an 
appreciation for how the sampling process makes a significant difference in 
the outcome. Second, meta-analysis has greatly contributed to an increased 
emphasis upon effect size and away from statistical significance. Effect size 
contributes new and in some cases, more meaningful information about 
relationships between variables. Third, meta-analysis has led to better 
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analytic methods for reviewing articles and synthesizing a large body of work 
in a given area. It has given to science, a more effective method of expressing 
results and for understanding the variability of research results. 
Schmidt ( 1992) posits that many scientists are frustrated with the 
progress which psychology has made in this century and that one of the 
reasons for the lack of progress is due to an over emphasis on statistical 
significance. He states, "traditional data analysis and interpretation 
procedures based on statistical significance tests mitigate against the 
discovery of the underlying regularities and relationships that are the 
foundation for scientific progress" (p. 1173). If a statistic is significant, then a 
relationship or effect is assumed and if the statistic is not significant, then the 
relationship does not exist. The basis for performing tests of significance is to 
control Type I errors, but there is little attention paid to control Type II errors. 
Type I errors are committed when it is assumed that a relationship exists, when 
in fact it does not. A Type II error exists when there is a true differences but it 
is missed, because it is assumed that no relationship exists. The current 
statistical procedures have quite effectively controlled Type I errors but Type 
II errors have by default been allowed to climb to high levels, often to the 
SOo/o-80% range (Cohen, 1990). Schmidt hypothesizes that as time goes by, in 
any particular research area, the knowledge and understanding get more and 
more precise. As a more dear understanding is gained in a particular area, 
the null hypothesis becomes less and less likely to be true. This indicates that 
researchers should increasingly pay more attention to statistical power. A 
review of an APA journal yielded a reduction in power from 46% to 37% during 
a 22 year span (Schmidt, 1992). A primary reason for the decline in power is 
the increased use of alpha-adjusted procedures such as the Newman-Keuls, 
Duncan and Scheffe', which. has yielded an additional increase in Type II 
errors of 17% (Schmidt, 1992). Schmidt's premise is that meta-analysis can 
effectively address many of the short-comings of statistical significance 
testing. 
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Meta-analysis provides empirical building blocks for theory 
development. A good theory is simply an effective explanation of the 
processes that actually take place in a phenomena. In order to construct an 
effective theory, one must know some of the basic facts such as the empirical 
relationships between the variables. When the relationships are quite varied 
across settings and populations, then complex interactive or moderator-based 
theories are necessary. Meta-analysis can greatly aide in understanding the 
complexities of relationships between variables and guide the theorist in 
developing comprehensive explanations. One of the primary reasons for 
science and theories is to establish causal explanations (Schmidt, 1'992). Path 
analysis is used to test causal theories and meta-analysis is a: useful building 
block to design accurate path analyses. Some people have said that meta-
analysis is just a new, more quantitative way to review the literature (Guzzo, 
Jackson & Katzell, 1986). Schmidt (1992) is quoted in the following, 
meta-analysis is much more than a new method for conducting reviews. 
The realities revealed about data and research findings by the 
principles of meta-analysis require major changes in our views of the 
individual empir,ical study, the nature of cumulative research 
knowledge, and the reward structure in the research enterprise. Meta-
analysis has explicated the critical role of sampling error, measurement 
error, and other artifacts in determining the observed findings and 
statistical power of individual studies. (p.. 1179) 
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The treatment of ADHD children and adolescents is a complex and 
confusing maze of research which many times does not clarify the variables 
but rather places greater confusion upon them. Because of the extreme 
variability of results in treating ADHD children, meta-analysis seems 
particularly well suited for this investigative adventure. Smith and Glass 
( 1977) investigated the effectiveness of psychotherapy by using meta-analysis 
and this presented a break-through study which has become the standard for 
all literature review procedures. Rather than ask the question, "Does 
psychotherapy work?", Smith and Glass taught us to ask what type of 
psychotherapy works best, with what clients, under what circumstances, with 
which disorders and with what type of therapist. This is the type of inquiry 
which needs to take place in the treatment of ADHD children and adolescents. 
A better understanding can be gained by a meta-analytic study of the various 
treatments for a ADHD, because successfully adapting individual treatment has 
already proven to be effective. It is obvious as one studies the literature 
involving ADHD children, that it is not a homogenous group but an incredibly 
diverse and complex group, which may in the future not even be considered a 
single diagnostic category. The future seems destined to provide a more 
accurate categorization of multiple sub-disorders of ADHD, which will then 
allow for inquiry of more homogenous subjects. Until that time, a clearer 
understanding can be gained by using meta-analysis to explain how the 





Chapter three describes the sample of studies, the review procedures for 
selection, the dependent measures used, and the type of analyses which will be 
performed. This study used meta-analytic procedures to investigate the 
effectiveness of pharmacological treatment for Attention-deficit 
Hyperactivity Disorder. Effectiveness is measured using many different types 
of outcome and this study sought to define whether medication is effective and 
if so, which type of medication resulted in the greatest improvement as 
measured by each of those outcome areas. The method of comparison will be to 
compute an effect size (A), which subtracts the mean of the medication from 
the placebo treatments and then divides that difference by the standard 
deviation of the placebo treatment. Effect size allows for a standardized 
measure so that direct comparisons can be made across many dependent 
measures and many studies. 
Sample 
This investigation surveyed the scientific periodicals to identify articles 
which reported the use of medication in the treatment of ADHD. Medline and 
Psychlit were utilized to locate the relevant articles. Medline is a computer 
data base which lists medical journals and Psychlit is a data base which lists 
psychological and educational journals. In an effort to obtain only those 
articles which utilized the DSM III R criteria to select subjects, the key words 
which were used in the search parameters included: ADHD and Attention-
deficit Hyperactive Disorder. The treatment parameters were further 
narrowed by using the key phrase "drug therapy". The exact search command 
entered was "ADHD or Attention Deficit Hyperactivity Disorder and Drug 
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Therapy". In order to keep the number of studies to a manageable number, 
and to review only the most current psychopharmacological treatments, the 
articles were included only for the years between 1989 to 1994 inclusive. A 
printout of 144 abstracts was obtained from Psych/it and 301 abstracts from 
Medline. The total set of articles was screened for duplications and when 
located, duplications were deleted. The list of abstracts was further screened 
and articles were deleted which did not include the following criteria: (a) at 
least six subjects in the treatment group, (b) include the use of medication and 
a placebo treatment, (c) m:eans and standard deviations of the medication and 
placebo treatments must be available for analysis ( d) the dependent variables 
in the study must fit into one of the nine categories previously described, and 
( e) must use original research rather than reporting the results from a 
previous study. There were 23 studies which met inclusion criteria but did not 
report the means or standard deviations. The primary authors were contacted 
by mail and the information was requested. Only one author was able to 
supply the needed information and this was included in this study. The 
computer search yielded many articles which included theoretical discussions 
of ADHD diagnosis or treatment. For purposes of this study they were not 
useful and were not included. After the screening took place, there were 41 
studies included for statistical analyses, which yielded 80 effects sizes. Some of 
the studies included more than one dosage rate of medication or more than one 
type of medication, therefore many of the studies included more than one 
effect size. The studies which used non medication methods of treatment; as 
well as medication were included but only the medication and placebo statistics 
were utilized. 
Using more than one effect size for each study introduces 
nonindependent measures, which violates one of the assumptions of 
inferential statistics. The loss of important information by averaging 
different outcomes into one measure for each study was weighed against the 
violation of statistical purity and it was determined that the lesser of the two 
ills was to use all measures separately. 
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There were 41 studies in which analysis was performed and they yielded 
80 distinct treatment conditions. The 80 treatment conditions were placed into 
nine sub-categories and averages were obtained for each of the nine sub-
categories for each of 80 unique medication and dosage rates. The nine sub-
category means were then averaged in order to obtain a global average for all 
treatment conditions. This yielded the possibility of 10 outcome measures for 
each medication or dosage rate. A breakdown for each year shows the 
following distribution: 10 studies in 1989, 6 in 1990, 9 in 1991, 8 in 1992, Sin 
1993 and 3 in 1994. The total number of subjects for all studies was 1,259; 
ninety three percent were male and seven percent were female. The mean 
age for all subjects used in the studies was 9.4 years old and the mean IQ was 
98.5. Three of the studies were primarily interested in the effects of 
medication on mentally retarded subjects and those three studies had a mean IQ 
of63.7. 
Many of the studies reported the existence of comorbid disorders in the 
ADHD subjects. The following percentages were computed from the total 
subject population for each disorder: 11.4% qualified for conduct disorder, 6.5% 
qualified for learning disabilities, 4.3% qualified for mental retardation, 2.2% 
qualified for an anxiety disorder and 20.4% qualified for oppositional defiant 
disorder. 
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The mean time in which the subjects were exposed to the treatment was 
2.09 weeks. The mean number of diagnostic procedures which the studies used 
to diagnose their subjects is 3.18. The mean number of subjects in the studies 
is 30.81, ranging from nine to one hundred sixty one. 
Review Procedures 
A copy of each article was obtained from library sources and 
information was recorded from each article. A recording instrument 
(Appendix A) was designed and utilized to obtain demographic information for 
each study, and to record each of the outcome measures. The information 
obtained from the studies included: year of publication of the study, sample 
size, the number of diagnostic levels used for inclusion, mean age of the 
subjects, the number of subjects with a comorbid disorder and type of disorder, 
weeks exposed to treatment, IQ of the subjects, how many of subjects in the 
treatment group were male or female and the type of medication and dosage 
rate. 
The sample size is defined as the number of subjects in the treatment 
group. The number of diagnostic levels utilized in the diagnostic procedure 
involves a multi-layered approach to assessing subjects for inclusion. Typical 
criteria might include teacher behavior ratings, parent behavior ratings, 
clinical interview by a mental health professional, behavioral observations 
and standardized tasks. A child must have a clinically significant score for 
each diagnostic level in order to be included in the ADHD treatment group, and 
when several diagnostic inclusion levels are utilized, it should provide the 
most accurate selection of ADHD subjects. 
The mean age of the treatment group and the gender of treatment group 
are self-explanatory. The existence of comorbid disorders is defined as the 
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existence of any disorders as defined by the DSM III-R which occur in addition 
to the existence of ADHD. Some typical comorbid disorders may include 
Oppositional Defiant Disorder, Conduct Disorder, Depression, Anxiety or 
Tourette's Syndrome. The IQ of the treatment group represents the measured 
mean intelligence of the treatment group based upon a standardized 
intelligence test. The weeks of treatment is defined as the number of weeks 
the subjects were exposed to the drug treatment and the category of medication 
is defined as the name of the drug which the treatment group was placed on 
during the treatment. There are two categories of medication: stimulants and 
antidepressants. The generic name of the drug will be reported in this study 
and drugs with the same chemical composition but simply different names will 
be combined into the same category. 
Some medication is titrated by fixed dosage rates and others use a 
variable ratio based upon the weight of the subjects; both methods will be 
utilized and reported in this study. Many of the studies compared dosage levels 
of the same medication to each other and reported dependent measures for 
each level. Three categories were utilized so that dosage rate levels could be 
compared to each other. The three levels used in this study were low, medium, 
and high. Both dosage types were used in the analysis of dose level. For the 
fixed rated format, a dose of 5 mg. constituted a low dose level. A dose of 10 mg. 
constituted a medium dose and any dose above 10 mg. was placed in the high 
dose level. For the variable format, dose rates from .1 mg./kg. to .3 mg.I kg. 
were placed in the low dose level, dose rates from .4 mg./kg. to .6 mg./kg. were 
placed in the medium dose level and any dose level above .6 mg.I kg. was 
placed in the high dose level category. 
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The assignment of dosage levels for the fixed method followed the 
recommendations within the literature which typically define a dose of 5 mg. 
as a low dose, a dose of 10 mg. as a medium dose and a dose of 10 mg or greater 
as a high dose. The studies which used the variable method contained nine 
different dosage rates. The lowest three were assigned to the low level, the 
middle three were assigned the medium level and the highest three were 
assigned the high level. Using this method resulted in an unequal number of 
treatment conditions being placed into the three categories but it provided the 
best possible separation between the dosage levels. Additionally, some studies 
administered medication one time per day, most two times per day and others 
three times per day. The dosage per administration was used in the 
categorization regardless of how many times per day the subject received the 
dose. All of the studies made certain to test the subjects at the most optimum 
time related to the administration of the medication, so for testing purposes it 
did not matter what other doses they received that day. This is true for 
stimulant medication because the half life of the medication is so short. 
Within four hours, all medication is metabolized in the body. 
Research designs include many different outcome measures to 
determine whether a child shows improvement from taking medicine. An 
attempt was made to cluster the various dependent measures into groups so 
that the results could be reduced to a few manageable categories. The outcome 
measures were sorted into nine general areas: parent behavior ratings, 
teacher behavior ratings, miscellaneous behavior ratings, academic 
achievement, standardized assessments, direct observation, social interaction, 
self-esteem and self rating. Average effect sizes were computed for each 
category, which were used in each of the treatment conditions, as well as a 
global average effect size of all nine categories. It should be noted that 
although there were only 41 studies, there were 80 treatment conditions; 
therefore, some of the studies included more than one treatment condition. 
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The above categories were chosen because they have broad application 
across many different assessment instruments. The category descriptions and 
names of the categories were chosen to allow the largest number of studies to 
be used and to maximize the accuracy of placing the dependent measurements 
into their proper categories. The categories were chosen by performing pilot 
procedures on 5 studies and listing all of the dependent measures for the pilot 
studies. After these pilot studies were coded, the dependent measures were 
placed into categories and S additional pilot studies were coded to verify the 
goodness of fit for the categories and adjustments were made as needed. 
In the early meta-analyses, combining very divergent heterogeneous 
outcome measures was commonly done, but this method tended to obscure 
meaningful differences in treatments and minimize the effectiveness of 
treatments (Crits-Christoph, 1992). This study will look at more precise 
breakdowns of outcome measures, as well as total effects, so that greater 
sensitivity may be obtained. 
The effect size (A) was calculated by using the work of Glass (1981). 
Effect size (A) is obtained by calculating the difference between the mean of 
the placebo treatment and the mean of the medication treatment and then 
dividing the result by the standard deviation of the placebo treatment. 
Calculations were made so that a positive effect size would indicate that the 
medication treatment was superior to the placebo and a negative effect size 
indicates a superiority of the placebo group. This allows for standardized 
statistics and consequently different types of measurements can be compared 
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on a common scale. An effect size of one indicates that the mean of the 
medication treatment is one standard deviation higher than the mean of the 
placebo treatment. Effect sizes will be obtained for all of the dependent 
measures and used to investigate which type of medication is most effective 
and in which area is it most effective? Furthermore, dosage rates will be 
measured separately to investigate which dosage rates are most effective in 
each of the categories. Dosage rates will be placed into category levels so that 
comparisons can be made between the dosage levels. Statistical analysis will 
be performed to determine whether effect size is influenced by sample size, IQ 
of the subjects, weeks exposed to treatment, age of subjects, and rigor of 
diagnostic criteria. Cohen (1977) suggested the following guidelines for 
interpreting effect sizes for the behavioral sciences: a value of .2 is considered 
a small effect size, a value of .5 is considered a medium effect size and a value 
of .8 is considered a large effect size. 
Current literature contains several different procedures to compute the 
effect size. Some studies yield just one effect size, while others yield multiple 
effect sizes (Baer & Nietzel, 1991). One way to calculate effect size is to include 
all of the outcome measures regardless of the sample size but this method 
results in obtaining non independent effect sizes, as well as a disproportionate 
weight for some studies. Another way to calculate effect size is to -compute an 
average effect size for each study so that each study contributes only one 
independent effect size to the total. This method allows for each study to 
contribute equal weight to the meta-analysis but does not allow for careful 
examination of each dependent measure and significant specificity is lost. A 
third method of determining effect size is to weight the individual effect sizes 
based upon the sample size, allowing for measures which are not independent 
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but do not place disproportionate weight on small samples that contain many 
measures. After careful consideration of the advantages and disadvantages of 
each of these three methods, it was decided that all dependent measures will be 
used and they will not be weighted. It was determined that this method will 
yield the most useful information, despite the lack of independence of the 
results and violation of assumptions underlying parametric statistics. 
Dependent Measures 
The dependent measures used in this study were limited by the selection 
process of the authors of the studies used in this meta-analysis. It does not 
represent a sample of all possible dependent measures which could have been 
used and to this extent it is biased. 
The dependent measures which were selected by the studies used in 
these analyses are all short-term in nature. The dependent measures in the 
field of ADHD research are consistently short-term and because of this are 
somewhat artificial. In real life, long-term benefits are more compelling and 
hold greater interest but are subject to so many influences that it is difficult to 
obtain specific measures. The more time which passes between treatment and 
measurement of any variable, the greater the external influences which act 
upon the variable. 
Most of the dependent variables are based upon the judgments of other 
people, rather than the objective behavior of the child. This method of 
obtaining measurements from significant observers does exert influence on 
the outcome of the measures obtained and are only as reliable as the observers 
judgment. The judgment of significant observers of ADHD children are 
effected by many influences and should not be viewed as objective. 
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Analyses 
To answer the research questions one through ten, an effect size will be 
computed and the work of Cohen ( 1977) will be used to measure the magnitude 
of the outcome effectiveness. The meaning of effect size is dependent upon 
the context in which it occurs, but Cohen suggested three categories be used in 
the behavioral sciences for interpretation of the results. As previously stated, 
Cohen suggested that a small effect size be defined as .2 standard deviations and 
anything smaller than .2 is not large enough to be meaningful. Cohen defined 
a medium effect size as .5 standard deviations and a large effect size is .8 
standard deviations. Most treatment effects in the behavioral sciences are 
small because there is simply too much variation that is due to a wide range of 
variables and the measures which are used in educational and psychological 
research are too imprecise (Cohen, 1988). 
Research question 11 will be evaluated by comparing the effect sizes 
obtained by averaging the nine outcome categories for stimulants and 
antidepressants and discussing the implications of the relative effect sizes of 
each. Because there is such a unequal number of studies between 
antidepressants and stimulants, an important assumption of parametric 
statistics is violated; therefore, inferential statistical analysis is not 
meaningful or prudent. Research question 12 will be answered by doing a one 
way ANOV A comparing the three dosage levels for each of the ten outcome 
categories and when significance is found, post hoc comparisons will be done 
to find the exact source of the significance. 
Research questions 13 through 1 7 will be evaluated by performing 
Pearson correlations and computing statistical significance for each of the ten 
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outcome categories. Only those measures which include at least 15 subjects in 
a cell will be conducted because anything less than 15 subjects does not follow 
prudent data analysis and would not have sufficient power to identify true 
differences. Research question 18 will be answered by comparing the global 
effect sizes for each of the different types of stimulant medications: MPH, 
Dexedrine, pemoline and MPH- Sustained Release. Inferential statistical 
analysis cannot be conducted because there is such an extreme difference in 
the sample size of the four types of stimulant medications. MPH was used in 
sixty-eight treatment conditions, Dexedrine in two treatment conditions, 
Pemoline was used in one and MPH-SR was used in four. 
Data collection was achieved by using a coding sheet (Appendix A) and 
obtaining pertinent information from each study. There was a limit set within 
each category in order to keep the number of measures to a manageable level. 
The category maximum was set high enough so that very few measures were 
not used individually. When the number of measures for any study exceeded 
the number of set categories, then averages were obtained so that they would 
fit the specified number. In this way, all outcome measures were used, but 
some were averaged. The maximum number of different outcome measures for 
each category was the following: 7 for parent behavior ratings, 7 for teacher 
behavior ratings, 7 for miscellaneous behavior ratings, 7 for academic 
achievement, 7 for standardized assessment, 7 for direct observation, 7 for 
social interaction, 6 for self rating, and 3 for self esteem rating. For example, 
if a treatment condition contained 8 dependent measures within the parent 
behavior ratings category, then two of the measures were averaged in order to 
fit within the maximum of 7 outcome measures. The dependent measures 
which were averaged were randomly selected so that no experimenter bias 
would occur. 
68 
The individual outcomes within the category were entered into the 
computer and an average effect size was calculated for each of the nine 
categories on the 80 different treatment conditions. The global average 
outcome category was obtained from the average of all nine categories for 
each of the 80 different treatment condition. A treatment condition represents 




This section presents the results of statistical analyses, including the 
effect sizes of each of the ten outcome measures. In addition, each of the 
research questions are addressed. This chapter is divided into two sections, 
descriptive statistics and research questions. 
Descriptive Statistics 
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Appendix B lists each of the studies with their effect sizes for the nine 
outcome sub-categories, along with the average of all outcome categories, 
which is referred to as global average. The primary author is listed and year 
of publication for each of the studies. Many of the studies have more than one 
treatment condition, consequently those studies list more than one set of effect 
sizes. 
Descriptive statistics are summarized in Table 1 for the ten outcome 
categories. Included in the table are the mean, standard deviation, minimum 
and maximum scores and the number of treatment conditions observed for 
each category. The category means range from a low of .32 for self rating, to a 
high of 1.02 for teacher behavior ratings. 
The five different types of medication were merged into one of two 
categories, stimulant and antidepressant. From the total of 80 treatment 
conditions, 75 (93.8%) utilized stimulants and 5 (6.2%) utilized antidepressants. 
Table 2 lists the effect size and number of occurrences for each of the ten 
outcome categories, subdivided by stimulant and antidepressant medication. It 
should be noted that studies of antidepressant treatments used only four. 
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Table 1 
Descriptive statistics (mean of effect sizes, standard deviation, minimum score, 
maximum score, and number of effect sizes) for each of the ten categorie.s. 
Category Minimum Maximum 
d SD Score Score n 
Academic achievement. .49 .36 .07 1.32 41 
Direct observation .68 .30 .26 1.48 41 
Misc~ behavior ratings .75 .62 .33 2.25 8 
Parent behavior ratings .63 .51 -.67 1.82 52 
Self esteem rating .40 .21 .07 .63 5 
Self rating .32 .12 .18 .47 8 
Social interaction .47 .31 .OS 1.22 19 
Standardized assessment .65 .58 .07 2.57 31 
Teacher behavior ratings 1.02 .85 -.12 4.51 44 
Global average .67 .52 .07 2.96 80 
Table 2 
Effect sizes and number of occurrences broken down by the type of 
medication. 
Anti-
C ategorv M easures s timulant deoressant 
A n A n 
Academic achievement. .49 41 0 
Direct observation .68 41 0 
Misc. Behavior Rat .52 6 1.44 2 
Parent behavior ratings .60 26 1.08 2 
Self esteem rating .40 5 0 
Self rating .32 8 0 
Social interaction .47 19 0 
Standardized assessment .56 27 1.27 4 
Teacher behavior ratings .87 38 2.32 5 
Global average .60 75 1.91 5 
Research Question 1 
Does the use of medication significantly improve the overall 
performance as measured by the average of all measures, of ADHD children 
and adolescents when compared to the placebo treatment? As can be seen 
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from Table l, there were 80 treatment conditions obtained for the global 
average category. When comparing medication treatment to placebo 
treatment, results of analysis indicate an average effect size for global average 
of .67, which according to Cohen is in the medium range. This means that a 
subject at the 50th percentile in the placebo treatment would be moved to the 
75th percentile when placed on medication. 
Research Question Z 
Does the use of medication significantly improve parent behavior 
ratings of the ADHD children when compared to the placebo treatment? As 
can be seen from Table l, there were 52 treatment conditions obtained for 
parent behavior ratings. When comparing medication treatment to placebo 
treatment, results of analysis indicate a treatment effect size for parent 
behavior rating scales of .63, which according to Cohen is in the medium 
range. This means that a subject at the 50th percentile in the placebo 
treatment would be moved to the 7 4th percentile when placed on medication. 
Research Question 3 
Does the use of medication significantly improve teacher behavior 
ratings of the ADHD children when compared to the placebo treatment? As 
can be seen from Table 1, there were 44 treatment conditions obtained for 
teacher behavior ratings. When comparing medication treatment to placebo 
treatment, results of analysis indicate a treatment effect size for teacher 
behavior ratings scales of 1.02, which according to Cohen is in the large 
range. This means that a subject at the 50th percentile in the placebo 
treatment would be moved to the 85th percentile when placed on medication. 
Research Question 4 
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Does the use of medication significantly improve the academic 
achievement of ADHD children, when compared to the placebo treatment? As 
can be seen from Table 1, there were 41 treatment conditions obtained for 
academic achievement. When comparing medication treatment to placebo 
treatment, results of analysis indicate a treatment effect size for academic 
achievement of .49, which according to Cohen is in the medium range. This 
means that a subject at the 50th percentile in the placebo treatment would be 
moved to the 69th percentile when placed on medication. 
Research Question 5 
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Does the use of medication significantly improve performance of the 
ADHD children on standardized assessments, when compared to the placebo 
treatment? As can be seen from Table 1, there were 31 treatment conditions 
obtained for standardized assessment. When comparing medication treatment 
to placebo treatment, results of analysis indicate a treatment effect size for 
standardized assessments of .65, which according to Cohen is in the medium 
range. This means that a subject at the 50th percentile in the placebo 
treatment would be moved to the 75th percentile when placed on medication. 
Research Question 6 
Does the use of medication significantly improve the behavior of ADHD 
children when compared to the placebo treatment, as measured by direct 
observation of their behavior? As can be seen from Table 1, there were 41 
treatment conditions obtained for direct observations. When comparing 
medication treatment to placebo treatment, results of analysis indicate a 
treatment effect size for direct observations of .68, which according to Cohen 
is in the medium range. This means that a subj.ect at the 50th percentile in the 
placebo treatment would be moved to the 75th percentile when placed on 
medication. 
Research Question 7 
Does the use of medication significantly improve the social interactions 
of the ADHD children, when compared to the placebo treatment? As can be 
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seen from Table 1, there were 19 treatment conditions obtained for social 
interactions. When comparing medication treatment to placebo treatment, 
results of analysis indicate a treatment effect size for social interactions of .4 7, 
which according to Cohen is in the medium range. This means that a subject at 
the 50th percentile in the placebo treatment would be moved to the 68th 
percentile when placed on medication. 
Research Question 8 
Does the use of medication significantly improve the self-esteem ratings 
of ADHD children, when compared to the placebo treatment? As can be seen 
from Table 1, there were 5 treatment conditions obtained for Self-Esteem. 
When comparing medication treatment to placebo treatment, results of 
analysis indicate a treatment effect size for self-esteem ratings of .40, which 
according to Cohen is in the small range. This means that a subject at the 50th 
percentile in the placebo treatment would be moved to the 66th percentile 
when placed on medication. 
Research Question 9. 
Does the use of medication significantly improve the self-ratings of 
ADHD children in various areas, when compared to the placebo treatment? As 
can be seen from Table 1, there were 8 treatment conditions obtained for self-
ratings. When comparing medication treatment to placebo treatment, results 
of analysis indicate a treatment effect size for self-ratings of .32, which 
according to Cohen is in the small range. This means that a subject at the 50th 
percentile in the placebo treatment would be moved to the 63rd percentile 
when placed on medication. 
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Research Question 10 
Does the use of medication improve the behavior ratings of people other 
than teachers and parents as compared to the placebo treatment ( e.g. 
clinicians, nurses or camp counselors)? As can be seen from Table 1, there 
were 8 treatment conditions obtained for miscellaneous behavior ratings. 
When comparing medication treatment to placebo treatment, results of 
analysis indicate a treatment effect size for miscellaneous behavior ratings of 
. 75, which according to Cohen is in the medium range. This means that a 
subject at the 50th percentile in the placebo treatment would be moved to the 
77th percentile when placed on medication. 
Research Question 11 
Will there be differences in the overall effectiveness between 
stimulants and antidepressants? Due to the small number of studies using 
antidepressants, inferential statistical analysis could not be conducted. To 
answer this question, comparisons can be made between stimulant and 
antidepressant effect sizes. Table 2 summarizes the effect sizes for each 
category of medication. The global average effect size of the treatment 
conditions for antidepressants was 1.91, which means that a subject at the 50th 
percentile in the placebo treatment group is moved to the 97th percentile 
when placed on antidepressants. The global average effect size of the outcome 
measures using stimulants was .60, which means that a subject at the 50th 
percentile in the placebo treatment would be moved to the 75th percentile 
when placed on medication. 
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Research QJ;Lestion 12 
Will there be differences between the low, medium, and high dosage 
levels for MPH medication, as measured by the ten outcome categories? This 
research question leads to the null hypothesis that there will be no significant 
differences between the effect sizes obtained from the different dosage levels 
of MPH medications, as measured by each of the ten categories. 
There were 69 treatment conditions which reported the dosage level for 
MPH. There are two formats in which dosage rates are calculated, a fixed dose 
and a variable dose based upon milligrams of medication per kilogram of body 
weight. Of the 69 treatment conditions used in the dosage level analysis, SO 
used the ratio method and 19 used the fixed method. Rates based upon both 
methods were used in the dose level analysis. For the fixed rate format, a dose 
of 5 mg, constituted a low dose level. A dose of 10 mg., constituted a medium 
dose and any dose above 10 mg. was placed in the high dose category. For the 
variable format, dose rates from .1 mg./kg. to .3 mg.I kg. were placed in the 
low dose level, dose rates from .4 mg.lkg. to .6 mg.ikg. were placed in the 
medium dose level and any dose level above .6 mg.I kg. was placed in the high 
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dose category. There were four treatment conditions which used MPH-SR and 
these were placed in the medium dose because clinically the sustained release 
formulation is used to replace a 10 mg dose, given twice per day. A few studies 
administered medication one time per day, most studies administered 
medication two times per day and a few three times per day. The dose given for 
each administration was used to categorize the dosage levels, regardless of how 
many times per day the subject received the dose. All of the studies made 
certain to test the subjects at the most optimal time, related to the 
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administration of the medication, so for testing purposes it did not matter what 
other doses the children received during the day. This is true for stimulant 
medication because the half life of the medication is so short. Within four 
hours, all of the medication is metabolized in the body. Table 3 summarizes the 
effect sizes and number of occurrences for all ten categories subdivided by the 
three levels of medication. 
Table 3 
Effect size means and number of occurrences broken down by the dosage JeveJ 
for those studies which used stimulant medication 
C ate gory M easures L ow Md" e 1um H" h . 1g 
A n A n A n 
Academic achievement. .38 14 .so 15 .73 8 
Direct observation .54 16 .74 16 .94 7 
Misc. Behavior Ratings .49 3 .56 3 0 
Parent behavior ratings .62 9 .58 12 .40 4 
Self esteem rating .29 3 .56 2 0 
Self rating .29 4 .31 3 .47 1 
Social interaction .33 7 AS 8 .85 2 
Standardized assessment .33 10 .80 10 .56 3 
Teacher beh. ratings .78 13 .90 16 1.16 6 
Global average .48 30 .65 30 .82 9 
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A One-Way Analysis of Variance (ANOVA) was calculated for each of the 
ten outcome measures to determine whether significant differences existed 
between the three dosage levels. When significant differences were found, 
post hoc comparisons were computed using the Tukey method of correction to 
control the familywise error rate. There were two outcome measures which 
achieved significance for dosage levels, direct observation and global average. 
Significant differences were found between the three dosage levels for direct 
observation outcome measure. Post hoc comparison for group differences 
found the significant difference to be between the low and high dosage level. 
Table 4 shows the results of the One-Way ANOVA for direct observation. 
Table 4 
Summary of analysis of variance for dosage 1evel on the standardized 
assessment outcome measure. 
Source D.F. Sum of Mean E 
Squares Square 
Between Groups 2 .8208 .4104 5.2569 .0099 
Within Groups 36 2.8104 .0781 
Total 38 3.6312 
Significant differences were found between the three dosage levels for 
the global average of the nine sub-categories. Post hoc analysis indicated that 
the significant group differences were between the low and high dosage 
levels. Table 5 shows the results of the One-Way ANOVA for the global average 
outcome measure. 
Table 5 
Summary of anaJysis of variance for dosage leveJ on the gJobaJ average. 
outcome measure. 
Source D.F. Sum of Mean E p 
Squares Square 
Between Groups 2 .9209 .4604 3.3741 .0403 
Within Groups 66 9.0063 .1365 
Total 68 9.9272 
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Post hoc analysis was conducted to get a better understanding of the 
relationship between the exact dose level and the magnitude of the effect sizes 
for the outcome measures. To understand the strength of association between 
the level of dose and effect size the variable and fixed method of computing the 
dosage levels were separated. Because it could be argued that the two methods 
of titrating doses are incompatible for comparison purposes in their raw form, 
the treatment conditions which used fixed and variable methods were split into 
separate files and analyzed independently. Pearson correlations were run for 
each of the ten outcome measures for the fixed and variable methods. Table 6 
summarizes the correlation coefficients, number of occurrences and actual 
probabilities for the fixed and variable methods. There were 21 treatment 
conditions which used the fixed method and 56 which used the variable 
method. 
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Correlational analysis found that none of the outcome measures had 
significant correlation coefficients for the fixed method of titrating doses. 
Analysis of the variable method of titrating doses yielded two significant 
outcome measures, direct observation and standardized assessments. The 
outcome measure of direct observation achieved a correlation of r = .3908, p = 
.048, which means that the higher the dose, the greater the effect size. Fifteen 
percent of the variance in the effect sizes for the outcome category of direct 
observation is attributable to the dose of MPH. The outcome measure of 
standardized assessment achieved a correlation of r = .8136, p = .000, which 
means that the higher the dose, the greater the effect size. Sixty-six percent 
of the variance in the effect sizes for the outcome category of standardized 
assessments is attributable to the dose of MPH. 
Research Question 13 
What is the relationship between the IQ of the subjects and their 
response to medication as measured by the ten outcome categories? This 
research question leads to the null hypothesis that there will be no linear 
relationship between the average IQ of the subjects and their response to 
medication. To test this hypothesis a Pearson Product Correlation was 
computed for IQ and the ten outcome measures. Table 7 reports the correlation 
coefficients, probabilities and number of observations for each of the ten 
measures. There was one outcome measure which obtained significant 
correlations, academic achievement. Academic achievement had a negative 
correlation oLr_= -.6399, p =.001, which means that the higher the IQ of the 
subjects, the lower the effect size they 
obtained. 
Table 6 
Correlation coefficients, number of occurrences and probabilities for dosage 
and outcome measures, spHt for the fixed and variable methods. 
Outcome Measure Fixed Variable 
r p n r p 
Academic achievement. -.1010 .681 19 .0674 .778 
Direct observation -.0199 .944 15 .3908 .048* 
Parent behavior ratings -.0804 .736 
Social interaction -.0126 .964 
Standardized assessment .8136 .000* 
Teacher behavior ratings. -.0029 .991 17 -.0618 .764 
Global avera2:e .0717 .757 21 .0338 .804 
Note=. Empty cells indicate less than 15 occurrences. Asterisk indicates 
significant coefficients at the .OS· level (2-tailed). 
Research Question 14 
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What is the relationship between the age of the subjects and their 
response to medication as measured by the ten outcome categories? This 
research question leads to the null hypothesis that there will be no linear 
relationship between the age of the subjects and their response to medication. 










Correlation Coefficients between IQ of the subjects and the ten outcome 
measures, as wen as the probabilities and the number of observations. 
Outcome Measure r p n 
Academic achievement. -.6399 .001* 24 
Direct observation -.3804 .098 20 
Standardized assessment .4169 .096 17 
Teacher behavior ratings -.2278 .308 44 
Global average .0764 .610 47 
Note_: Asterisk denotes statistical significance at the .OS level (2-tailed). 
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outcome measures. Table 8 reports the correlation coefficients, probabilities 
and number of observations for each of the ten measures for age. Two 
significant outcome correlations were obtained for the variable of the mean 
age of the subjects, academic achievement and global average. Academic 
achievement obtained a correlation of r= -.3399, p= .034, which means that the 
younger the child, the better he/ she responded to medication, as measured by 
academic achievement. global average obtained a correlation of r= -.2851, 
p=.015, which means that the younger the child, the better he/she responded 
to medication, as measured by the average of all measures. 
Table 8 
Correlation Coefficients between age of the subjects and the ten outcome 
measures, as well as the probabilities · and the number of observations. 
Outcome Measure r p n 
Academic achievement. -.3399 .034* 39 
Direct observation -.2681 .109 37 
Parent behavior ratings -.226 .285 25 
Social interaction -.3107 .225 17 
Standardized assessment -.2208 .289 25 
Teacher behavior ratings -.3042 .076 35 
Global average -.2851 .015* 72 
Note.: Asterisk denotes statistical significance at the .OS level (2-tailed). 
Research Question 1 5 
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What is the relationship between the level of rigor which the studies 
used to select subjects and the ten outcome categories? This research question 
leads to the null hypothesis that there will be no relationship between the 
number of levels of diagnostic inclusion and the effectiveness of medication. 
To test this hypothesis, Pearson correlations were computed for the number of 
levels of inclusion ( diagnostic rigor) and each of the ten outcome measures. 
There were four correlation coefficients which reached significance, with 
three being negatively correlated and one positively correlated. The results 
for all ten measures are summarized in Table 9. Parent behavior ratings 
obtained a correlation of r=-.4698, p= .010, which means that those studies 
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which used more rigor in their diagnostic procedures reported smaller effect 
sizes. Standardized achievement obtained a correlation of r= -.4166, :p= .022, 
which means that those studies which used more rigor in their diagnostic 
procedures reported smaller effect sizes on the outcome measure of 
standardized assessments. Teacher behavior ratings obtained a correlation of 
r= -.3508, p= .020, which means that those studies which used more rigor in 
their diagnostic procedures reported smaller effect sizes on the outcome 
measure of teacher behavior ratings. Social interaction obtained a correlation 
of r= .5592, :p= .013, which means that those studies which used more rigor in 
their diagnostic procedures reported greater effect sizes on the outcome 
measure of social interaction. 
Research Question 16 
What is the relationship between the number of subjects in the studies 
and the ten outcome categories for all medications? This research question 
leads to the null hypothesis that there will be no relationship between the 
number of subjects and the effectiveness of medication. To test this 
hypothesis, Pearson correlations were computed for the ten outcome measures 
and the number of subjects in the studies. The results of the correlations are 
summarized in Table 10. The only significant correlation coefficient obtained 
for sample size was on the outcome measure of direct observation. Direct 
observation obtained a correlation of r= -.3317, p= .034, which means that the 
smaller the sample size of a study, the larger the effect size which was 
obtained. 
Table 9 
Correlation Coefficients between level of rigor in selecting subjects and the 
ten outcome measures, as we11 as the probabiHties and the number of 
observations. 
Outcome Measure r p n 
Academic achievement. .1347 .414 39 
Direct observation -.0452 .785 39 
Parent behavior ratings -.4698 .010* 29 
Social interaction .5592 .013* 19 
Standardized assessment -.4166 .022* 30 
Teacher behavior ratings -.3508 .020* 44 
Global average -.2131 .063 77 
Note.: Asterisk denotes statistical significance at the .OS level (2-tailed). 
Research Question 17 
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What is the relationship between the number of weeks exposed to 
treatment and the global improvements?. This research question leads to the 
null hypothesis that there will be no relationship between the number of 
weeks of exposure to treatment and the effectiveness of medication. This 
hypothesis was tested by performing Pearson correlations for each of the ten 
outcome measures and the number of weeks the subjects were exposed to 
treatment. Results of the correlational analyses are presented in Table 11. 
Parent behavior ratings and teacher behavior ratings were the only two 
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Table 10 
Correlation Coefficients between the number of subjects and the ten outcome 
measures, as wen as the probabilities and the number of observations. 
Outcome Measure r p n 
Academic achievement. -.1711 .285 41 
Direct observation -.3317 .034* 41 
.Parent behavior ratings -.1509 .435 29 
Social interaction -.3161 .187 19 
Standardized assessment -.2956 .106 31 
Teacher behavior ratings -.2274 .138 41 
Global average -.1940 ·.083 80 
Note.: Asterisk denotes statistical significance at the .OS level (2-tailed). 
which achieved significance and both were negatively correlated. Parent 
behavior ratings obtained a correlation of r= -.3749, p_=.049, and teacher 
behavior ratings obtained a correlation of r= -.3409, p_= .031. This means that 
for both behavior ratings the longer the subjects were exposed to treatment, 
the smaller the effect sizes were likely to be. 
Research Question 1 8 
Are there any differences between the different types of stimulant 
medication, as measured by the average of the nine outcome categories? This 
research question leads to the null hypothesis that there will be no 
differences between the four types of stimulant medication in their 
effectiveness. Due to the severe inequality in the number of studies using the 
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four types of medication, inferential statistical analysis could not be 
conducted. Table 12 summarizes the effect sizes of each of the four types of 
stimulant medication. The global average effect size for the studies using MPH 
is .58 which according to Cohen is in the medium category. This means that a 
subject at the 50th percentile in the placebo treatment group was moved to the 
72nd percentile when given MPH. The global average effect size for the 
studies using Dexedrine is .44 which according to Cohen is in the small 
category. This means that a subject in the placebo group at the 50th percentile 
was moved to the 67th percentile when placed on Dexedrine. The global 
average effect size for the studies using MPH-SR is .97 which according to 
Cohen is in the large category. This means that a subject in the placebo group 
at the 50th percentile was moved to the 83rd percentile when placed on MPH-
SR. The global effect size for the studies using Pemoline is .52 which 
according to Cohen is in the medium range. This means that a subject in the 
placebo group at the 50th percentile was moved to the 70th percentile when 
placed on Pemoline. 
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Table 11 
Correlation Coefficients between the number of weeks the subjects were 
exposed to treatment and the ten outcoDJe measures, as wen as the probabilities 
and the number of observations. 
Outcome Measure r p n 
Academic achievement. -.1475 .384 37 
Direct observation -.2409 .134 40 
Parent behavior ratings -.3749 .049 28 
Social interaction -.1412 .600 16 
Standardized assessment .2645 .201 25 
Teacher behavior ratings -.3409 .031 40 
Global average -.0796 .525 66 
Note: Asterisk denotes statistical significance at the .OS level (2-tailed). 
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Table 12 
Mean effect sizes and number of observations broken down b)!: the t)!:pe of 
stimulant medication used in the stud)!: for each outcome categ.ory_._ 
C ategory M easures MPH D exe d" nne MPH SR - p 1· emo 1ne 
/J. n 11 n 11 n 11 n 
Academic achievement. .51 36 .39 2 .34 2 .32 1 
Direct observation .70 38 .54 1 .41 1 .46 1 
Misc. Behavior Rat .52 6 0 0 0 
Parent behavior ratings .52 24 0 1.65 2 0 
Self esteem rating .40 5 0 0 0 
Self rating .32 8 0 0 0 
Social interaction .43 16 54 1 .68 1 .89 1 
Standardized assessment .48 24 .39 1 1.70 2 0 
Teacher behavior ratings .89 33 .41 1 .95 3 .39 1 






It has been previously discussed in this study that ADHD children lack 
insight into their own behavior and don't seem to be good judges about how 
their behavior is impacting those around them. The two category outcomes 
which involve internal processes and self-awareness include the self-rating 
and self-esteem sub-categories. The average effect size for these two 
categories is .36. These measures are the two lowest effect sizes obtained in 
this analysis, which seems to support the idea that the children have a deficit 
of self-awareness and may be under estimating the improvement they 
experience after taking medication. 
There are three outcome measures which involve behavior ratings by 
observers of the child's behavior, parent behavior ratings, teacher behavior 
ratings and miscellaneous behavior ratings. These three behavior ratings 
include people who interact closely and consistently with the child and 
usually have an in-depth understanding of the child's behavior. The average 
effect size for the three behavior ratings is .80. Contrast this effect size with 
the self-awareness effect size previously discussed, and there is substantial 
difference between the two ratings. Teacher's rated the children more 
improved after medication than any other outcome sub-category. Typically 
the medication is taken during the school hours; therefore, it is not 
surprising that teachers would see the greatest improvement. Furthermore, 
the demands place upon the ADHD child by school are the type which place the 
greatest strain on their attention, motivation and behavioral inhibition. Since 
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the unmedicated child is likely to have the greatest difficulty at school, it is 
predictable that upon being placed on medication, the child would show the 
greatest improvement at school. Intuitively, it also seems that teachers are 
more objective than parents in rating the child's behavior because they 
usually have more emotional distance and are less likely to get into a conflict 
loop with the ADHD child. Teachers also have the benefit of comparing the 
ADHD child with many other children of the same age in order to make more 
accurate behavioral judgments. 
The parent behavior ratings may be affected by many factors including 
those discussed in the previous paragraph. An important aspect of the typical 
medication strategy is to give the child medicine only during the time when 
he/she is at school and consequently many times the medication has worn off 
when the child is at home. The parents do not rate the benefits of medication 
as positively as teachers because the medication has worn off and in fact the 
child may be suffering from the rebound effects of not being under the 
influence of the medication. Another important factor in the smaller parent 
behavior rating effect sizes is due to the complex psychosocial relationships in 
the family. The conflict between parent and child is not only influenced by 
the child's disorder but also by the family stressors, parental psychopathology 
and there is frequently secondary gain which will work to prevent the child 
from changing his/her behavior at home. The fact that the medication 
improves the parent ratings in spite of all of these negative factors is 
remarkable. 
The 80 treatment conditions which are reported in this study are 
composed of 7 5 stimulants and five antidepressants. This inequality is 
indicative of the inequality of both the ADHD research and clinical use. The 75 
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stimulant treatment outcomes were also not equally distributed among the four 
types of medication, with 68 out of the 75 using MPH. The extreme difference 
in the number of studies for both of these categories precluded the inferential 
statistical analysis; therefore, it is more useful to discuss the meaning of the 
different effect sizes in a qualitative way. The global effect size for stimulants 
was .60 and for antidepressants it was 1.91. Even though antidepressants were 
utilized in only four sub-categories out of nine, the global average effect size 
obtained was more than three times that obtained for stimulants. In spite of 
the small sample size, this finding is significant and an attempt should be 
made to understand these striking results. Another way to look at the 
difference between the treatment of stimulants and antidepressants is that a 
subject at the 50th percentile in the stimulant group would be moved to the 
90th percentile when placed on antidepressant medication. Since there are 
only a few studies which used antidepressants, caution should be used in 
forming any firm conclusions. This finding should serve to increase the 
future research in the area of antidepressants in order to verify whether 
these results can be replicated. 
A partial explanation for the difference in the effectiveness between 
stimulants and antidepressants can be understood in the divergent ways the 
two medications work. Stimulants are activated in the body within minutes of 
consumption and are metabolized from the body within four hours. There is 
no need to gradually build up dosage levels and in fact, there is no buildup in 
the body at all. Stimulants are effective only within four hours of their 
administration, while most antidepressants conversely take approximately 30 
days to stabilize their therapeutic levels, and once obtained they are active in 
the body 24 hours per day. When a child takes antidepressants, he/she is 
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receiving benefit in all types of settings, rather than only at school, as is the 
case with stimulants. 
An additional factor which may contribute to the increased 
effectiveness of antidepressants is that many of the ADHD children are 
experiencing depression (Breen & Barkley, 1983; Barkley, 1992b; Gottschalk, 
Swanson, Hoigaard-Martin, Gilbert & Fiore, 1984; Barkley, DuPaul & Murray, 
1990). The antidepressant medication may be treating the symptoms of 
depression, as well as the symptoms for ADHD, and when the depression is 
lifted, the child's behavior improves in two ways. Part of the symptoms for 
depression overlap with ADHD such as restlessness, concentration problems, 
emotional lability, sleep disturbance and psycho-motor agitation. An area 
which needs more study to tease out the medication effects and the individual 
affective problems is to control for the effects of antidepressants versus 
stimulants for those children who suffer from depression or dysthymia. 
The different way that stimulants and antidepressants work in the body 
accounts in part for the disparity in the published research for each of the 
medications. Stimulants are much more time efficient because of the 
immediate action; studies using stimulants can be completed in about one-
fourth the time it takes for antidepressants. Because antidepressants take 30 
days to stabilize, it will take several months to complete a study with more than 
one dosage level. Many of the studies using stimulants are completed with a 
single dosage level in one day, which makes research using stimulants far 
more cost effective in time and money. Additionally, when studies need more 
time to titrate the dosage until the most effective dosage is determined, this can 
prolong the studies using antidepressants even further. With increased 
pressure on scientists to maximize their results in order to justify their 
research money, the likelihood is for continued emphasis on stimulant 
medications. 
When One-Way ANOVA's were run for dosage level, there were two 
outcome measures which were significantly different. Standardized 
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assessment E(2,25) = 3.76, :p = .0375 and global average E(2,71) = 5.5379, :p = .0058 
were the two outcome measures which had significant differences between 
the dosage levels. Post hoc comparisons found for both sub-categories that 
group differences were between the low and high dosage level. Standardized 
assessment was barely significant but as previously discussed all of the effect 
sizes are conservative; therefore, it was deemed unnecessary to alter the alpha 
values to correct for the ten One-Way ANOVAs. The global average due in part 
to the higher number of observations, showed robust differences. The 
analysis comparing group differences provides strong support that higher 
doses lead to greater improvement globally. 
In order to get more sensitivity in measuring the relationship between 
effect sizes and actual dosages, Pearson correlations were computed for the 
medication dose and the ten outcome measures. It was necessary to separate 
the two methods of dose titration because of the lack of conformity in the two 
systems. Three of the outcome measures (parent behavior ratings, social 
interactions standardized assessment) for fixed method had meaningful 
correlations but because of the small number of occurrences, they lacked 
sufficient power to reach statistical significance. The variable method of dose 
titration resulted in two significant outcome measures, direct observation r = 
.3908, :p = .048 and standardized assessment r = .. 8136, :p = .000. The positive 
correlations indicate that the higher the dose, the greater the effect sizes in 
the two categories. The actual dose of MPH account for 66% of the variance in 
the outcome measure of standardized assessment. It is amazingly high for a 
single variable to explain that much variation in another variable. The 
95 
results are especially meaningful because the type of instn.1ments which make 
up this category have excellent reliability and validity in measuring the 
symptoms of ADHD. An effort should be made to find the lowest dose which is 
effective but there is consistent evidence which supports more effective 
change at the hig4er doses. 
There were several problems encountered in trying to place the data for 
dose level into a meaningful organization. Some of the doses were 
administered one time per day, most commonly two times per day and some 
even three times per day. It was difficult to decide whether to categorize the 
dosage levels based upon total per day rates or per each administration. 
Additionally, when dosage rates were computed by the variable method of 
mg/kg, most of the studies had ceilings for maximum dosage rates so that the 
ratio did not hold true for the larger subjects. Some of the studies used 
different rates for each subject and o.ther studies gradually altered the rate of 
dosage based upon effectiveness or gradually increased the dosage levels until 
a certain level was reached. All of these factors made it hard to place the 
individual dosage levels across studies into any type of meaningful categories 
that follow a consistent strategy. 
There is a common belief that ADHD children with low IQs do not benefit 
in school from taking medication; however, there has been little research to 
actually confirm or deny this belief. A compelling finding in this study is the 
negative correlation.L= -.6399, p =.001 for the sub-categories of academic 
achievement with IQ, The negative correlation indicates that the lower the IQ 
of the subjects, the more improvement academically they are likely to 
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experience. This is just the opposite of what would be expected based upon the 
literature. It may be the result of a ceiling effect for the subjects with higher 
IQs, in that they don't have as much room for improvement because they are at 
a higher level already. In effect, it may be "regression to the mean" working 
on the scores . which pulls the high IQ subjects down and the low IQ subjects up. 
There is a question as to whether an accurate IQ score can be obtained from a 
child with ADHD because not only does ADHD impair past learning, but it also 
impairs the test performance to some extent. There are some subtests on all IQ 
tests which measure past learning and other subtests which are sensitive to 
attention and concentration. The deficits which ADHD children commonly 
experience will place them at a disadvantage on those tasks which sample 
previous learning or attention and make IQ scores for ADHD children subject 
to much greater variability. 
Another factor which might partially explain the negative correlation 
between IQ and academic achievement is to analyze the three studies that 
yielded six treatment conditions which specifically tested mentally retarded 
ADHD children (Aman, Kem, McGhee & Arnold, 1993; Handen, Breaux, Gosling, 
Ploof & Feldman, 1990; Handen, Breaux, Gosling, Ploof & Feldman, 1992). The 
mean IQ for the subjects in the three studies were 65, 65 and 61, which are 
significantly below the other studies included in this analysis. Sixty four 
percent of the treatment conditions involved subjects with an IQ between 95 
and 105. If the three studies which measured mentally retarded children were 
deleted, then the mean IQ of the subjects moves from 98 to 104. The three 
studies which used mentally retarded children found significant effects for 
medication and especially for academic achievement outcomes. It is 
interesting to note that 42% of the treatment conditions did not report IQ 
scores which would seem to be an important variable to control in any 
research involving ADHD children. 
97 
Contrasting the negative correlation for academic achievement, the 
parent behavior ratings had an equally strong correlation but it was positive r 
= .6635, :p = .01. The ADHD children with higher IQs were more likely to be rated 
with greater improvement from taking medication by their parents. The 
studies which involved mentally retarded children had only one treatment 
condition which involved parent behavior ratings; therefore, the impact of 
those studies was minimal. It is possible that the children with higher IQs 
were able to make better use of the medication to conform their behavior at 
home in order to meet parental expectations. At any rate, 44% of the variance 
in parent behavior ratings is accounted for by IQ, which is considered a very 
meaningful association. 
How the age of the ADHD subjects affects their response to medication is 
an interesting question. The literature and clinical experience predict that 
children would have a more favorable response to medication than 
adolescents. This study supports that belief because nine out of the ten 
outcome measures had negative correlations with age. Several of the outcome 
measures did not achieve significance because of insufficient power; however, 
two of the outcome measures did achieve statistical significance, academic 
achievement and global average. Twelve percent of the variance in academic 
achievement and eight percent in global average is explained by the age of 
the subjects. It is likely that younger children respond to medication in 
general, more favorably because as the child gets older and develops habitual 
but ineffective learning strategies, the academic problems become less caused 
by neurological deficits and more due to other factors. It seems critical to 
98 
identify ADHD children as soon as possible and give medication a chance, so 
that academic discouragement does not become a pattern which if untreated, is 
difficult to alter. 
Analyzing the relationship between the number of weeks which the 
subjects were exposed to treatment and the effectiveness of medication was 
thought to be meaningful. It resulted in only one mildly significant 
correlation coefficient which was negative. Because stimulant medication is 
so fast acting and does not accumulate in the body, it probably is not important 
how long the treatment is administered. It is interesting that nine out of the 
ten outcome measures were negative, which indicates that the shorter 
treatments resulted in bigger effect sizes. Another phenomena is that 
antidepressants tend to involve longer treatment schedules and since 
antidepressants had higher effect sizes, it seems even more likely that 
treatment outcomes for stimulants are inversely related to the time the 
subjects are exposed to treatment. The most plausible explanation for the 
negative relationship between time and effect size is that the closer in time 
the placebo and medication treatments occur, the sharper the contrast, and 
therefore the higher the effect sizes. When the exposure to medication is 
longer then perhaps there is a tendency to forget how much improved the 
behavior really is, because in essence the raters may become desensitized. 
As previously discussed, the use of stimulants has been heavily slanted 
toward MPH in the literature and it was born out by this meta-analysis. 
Because of the inequality in the number of studies which used dexedrine, 
pemoline and sustained release MPH, it is not possible to make meaningful 
statistical comparisons. However, comparing MPH and MPH-SR for the ten 
categories provides some interesting patterns which merit discussion. Caution 
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should be exercised since there were only 4 treatment conditions that used 
MPH-SR, as compared to 68 which used MPH. The sustained release formulation 
of MPH is suppose to maintain its effectiveness for eight hours, compared .to 
four hours for the regular formulation. 
The teacher behavior ratings for the two forms of MPH did not differ 
with MPH obtaining an effect size of .89 and MPH-SR obtaining an effect size 
of . 95. However, there were several other outcome measures which resulted in 
meaningful differences, all of thein in favor of MPH-SR. Parent behavior 
ratings effect size for MPH was .52 and for MPH-SR it was 1.65; which is more 
than three times greater. As was previously discussed, when children receive 
MPH at school, many times they don't receive any benefit when they go home 
because the medication is already out of their system. Apparently, the MPH-SR 
is providing significantly more symptom relief at home than is the MPH . 
because the parents are seeing symptom improvement in a totally different 
way than the teachers do. 
The global average for MPH was .58, compared to .97 for MPH-SR , which 
is nearly double the effect size. Standardized assessments yielded an even 
larger disparity between the two formulations with the sustained release 
obtaining slightly over three and one half times the effect size of the standard 
formulation of MPH. This is both impressive and puzzling because the 
standardized assessment instruments are time limited and is would seem that no 
benefit would be received by the sustained release form but there appears to 
be a significant benefit in the way the MPH-SR is released in the body. 
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Methodo1ogical Issues 
The present meta-analytic study indicates that medication is more 
effective than placebo in the treatment of ADHD children and adolescents. ln 
all nine of the outcome sub-categories there were positive effect sizes ranging 
from .32 to 1.02, with an average effect size for all nine sub-categories of .67. 
All of the studies used in this meta-analysis involved subjects serving as their 
own control by taking both the placebo and medication treatments. The 
procedure for determining effect sizes which is typically used in meta-
analysis assumes that there is no correlation between the dependent measures 
or between the placebo and medication treatments. Since the studies used in 
this meta-analysis were repeated measures, there is a significant amount of 
unmeasured correlation. With the use of placebo and medication treatments 
by the same subjects, it can be assumed that all variance between the two 
measures is due to treatment effects. The use of highly correlated scores 
results in underestimating the effects of treatment but there is not sufficient 
information to determine the exact degree of the underestimation. In order to 
make the correct adjustments to the effect sizes .obtained in this study it would 
be necessary to know the correlations between the subjects placebo and 
medication· scores for each of the studies. Any conclusions which are drawn 
from this study should be influenced by the fact that the effect sizes are 
highly conservative and in all likelihood are actually higher than those 
stated. 
There are many excellent measures which are sensitive to the positive 
effects of medication and have very good reliability and validity. A trend was 
noticed in compiling the studies used in this meta-analysis that many of the 
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studies used newly designed or not widely distributed instruments for 
dependent measures. Typically, the standard instruments were used in the 
diagnosis of ADHD subjects but a different set of instruments was used to 
measure the effectiveness of medication. lt is likely that at least some of the 
instruments used to determine the effect sizes in this study lack sufficient 
validity to measure the symptoms associated with ADHD. Part of the reason for 
the use of unique instruments is that many of the studies were interested in 
very specific aspects of ADHD symptoms and no standardized instruments are 
available to measure the specialized behavior. The use of newer and less 
validated instruments probably altered the obtained effect sizes for all 
medication treatments. 
One major advantage of conducting meta-analysis is to look critically at 
the methodological issues and in particular methodological weaknesses within 
a body of research. As one tries to collect data from the various studies it 
becomes clear when there are weaknesses in the design or data reporting and 
it allows future scientists to remedy the weaknesses. What information is 
reported, how it is collected and coded are all issues in which the experimenter 
becomes much more sensitized by doing meta-analysis. Flaws in the literature 
become abundantly clear as one collects data from multiple studies and tries to 
make some sense of it. 
The care and accuracy in which subjects are chosen to participate in an 
experiment is a critically important factor and if not properly done, can be a 
source of experimental bias. It is fundamental when conducting research on a 
sample of subjects with a specified disorder, that the subjects are accurately 
diagnosed for inclusion. The number of inclusion levels is a way to quantify 
the rigor in which each study controlled the purity of its subject sample. 
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Theoretically the more rigorous the selection procedures, the more accurate 
the selection process and the higher the effect sizes obtained. Of the four 
significant correlation coefficients obtained, three were negative and one was 
positive. Parent and teacher behavior ratings obtained correlation 
coefficients of -.47 and -.35 respectively, while standardized assessment 
obtained a correlation coefficient of -.42. Even though they are significant, 
they are not large coefficients and the rigor of subject selection explains 
approximately 17% of the variance in each of the three outcome measures. 
The significant results could be due to chance but if it is due to experimenter 
bias it is likely to be influenced by chance within each study. When subject 
selection is influenced by chance occurrences, then experimental results are 
likely to fluctuate and achieve spurious and inconsistent results. 
When the search for relevant articles was begun by computer, the 
abstracts listed during the years from 1989 to 1994 numbered 445. After 
screening and careful analysis of the articles, only 41 were left which met the 
criteria of this meta-analysis. Many of the articles involved theoretical issues, 
case studies or opinions about ADHD but not true empirical research. There 
were 27 studies which did not report means and standard deviations and 15 had 
no placebo treatment but rather did a pre and post medication measurement. 
Perhaps the reason why so few empirical studies are being published which 
tests the effectiveness of medication is that so much previous research has 
been conducted that the scientific community believes that there is no need to 
prove over and over again that medication is effective. 
A compelling trend which was noticed but is outside the parameters of 
this study was the powerful effect that the placebo treatment had on all 
measures. It is likely that if the placebo effect had not been so strong, the 
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effect sizes for medication would have been even larger. Most of the behavior 
rating scales are scored such that a high score represents problem behavior so 
that when the placebo treatment lowered a particular factor score to half what 
it was prior to treatment, then it limited the amount of improvement which the 
medication could have. It limited the potential variability for the medication 
treatment and limited the effect size potential. 
Another factor which influenced the results of this study was the 
extreme variability in the placebo treatment. There were times when the 
standard deviation was significantly higher than the mean for the placebo 
and so even when the difference between the means for placebo and 
medication treatments were very large, the effect size that resulted was quite 
low. 
Limitations 
An attempt was made in this study to find a way to categorize all of the 
outcome measures into a consistent and meaningful system which made 
intuitive sense and could be replicated by others. Realistically, the labeling of 
outcome measures into categories in this study represent the work of one 
individual and it is likely that if others attempted· to perform the same work 
there would be some differences in the way that outcome measures would be 
labeled. It is a beginning but certainly not an end in the meta-analytic study 
of ADHD children. 
The dependent measures which were studies in these analyses were 
restricted to the dependent measures selected by the authors of the articles 
used. This has inherent limitations and generalizability should be carefully 
approached regarding behaviors in ADHD children which were not used in 
this meta-analysis. Furthermore, it is important to note that all of the 
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dependent measures are short-term in nature. All of the authors used 
dependent measures which could be measured within weeks of beginning the 
treatment and so long-term measures are not represented in any of the studies. 
No conclusions can be drawn about the long-term efficacy of medication based 
upon this study. 
The decision as to whether to place a child on medication for ADHD is a 
complex and individual matter. This study only investigated the positive 
effects of medication and does not pretend to present all sides equally in the 
question as to whether to place a child on medication. Any time a child is 
placed on medication it should be done cautiously and judiciously. Other 
treatments which are less invasive should be tried first or at least 
simultaneously with medication. 
Another limitation of this study is that no adults were included in this 
analyses. All of the subjects used in this study were under the age of 18 and no 
conclusions can be drawn from this study regarding the effectiveness of any 
type of medication for adults with ADHD. There are few studies to date which 
investigate the efficacy of placing ADHD adults on medication and so it is 
unlikely that a meta-analysis of this type could even be conducted. 
Future Research 
Of the 41 studies utilized in this meta-analysis none reported depression 
and only seven reported dysthymia among the subjects under study. Some of 
the literature has found the incidence of either depression or dysthymia 
among ADHD children to be much higher than in the normal population 
(Barkley, 1990). The lack of reporting of depression in the studies seems to 
indicate that there was a significant variable which was not controlled and it 
is likely that it impacted the way in which children responded to medication. 
105 
Future research should do a more effective job of controlling comorbid 
disorders and in particular depression and dysthymia. Comparisons between 
stimulants and antidepressants for children who suffer from depression 
should be performed to get a better understanding of the relationship between 
depression and the different types of medication. 
Summary 
In doing a meta-analytic study of the effectiveness of medication with 
ADHD children, it was hoped that it would prO\ide a baseline so that other types 
treatments could be compared to medication. Furthermore, it seems that 
combinations of treatments may hold the greatest hope so that different 
treatments can be matched with the desire to change the different outcome 
measures. Some children may experience differing levels of disturbance in 
each of the nine outcome measures which were used in this study. It was 
learned from this study that not all of the outcome measures were improved 
equally from medication. Perhaps other types of treatment would specifically 
be more effective in those areas where medication is not so effective. Even 
within the use of medication for treatment of ADHD, there is sparse literature 
on any medication except MPH. There were several findings which merit a 
closer investigation for the use of MPH-SR and antidepressants. Hopefully, 
this work can be continued by others so that the questions raised in this study 
can be answered. 
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